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In an effort to control the morbidity and mortality associated with human malaria, 
transmission-blocking vaccines have been given careful consideration as a means of 
halting the spread of the disease (Mendis et al., 1990). The main objective of a 
transmission-blocking vaccine is to prevent mosquitoes from becoming carriers of the 
parasite which causes malaria. Parasites in the form of sporozoites are deposited into the 
bloodstream of a human when a mosquito takes a bloodmeal. This is the beginning of a 
cycle of infection that proceeds in the human host culminating in the production of both 
asexually and sexually reproducing parasites. When a mosquito takes an infectious 
bloodmeal, the parasite undergoes further maturation in the mosquito midgut enabling it to 
be transmitted to another human. Parasite maturation and subsequent transmission can be 
blocked if antibodies which recognize parasite surf ace proteins are also present in the 
bloodmeal. The focus of this project is on the production of a recombinant protein that can 
be tested for its ability to induce malaria transmission-blocking immunity. This target 
antigen is Pfs230 which is found on the surface of the sexual stages of Plasmodium 
falciparum (P. falciparum), the parasite responsible for causing the most virulent form of 
human malaria. 
Pfs230 was first identified as a malaria transmission-blocking vaccine candidate by 
Rener et al. who found the protein to be the target of monoclonal antibodies that reduce 
parasite infectivity in the mosquito midgut (Rener et al., 1983). Recently, six regions of 
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Pfs230 were expressed as fusions with maltose-binding protein (MBP) in Escherichia coli 
(E. coli) (Williamson et al., 1995). Antisera against one of those six regions, 
r230.MBP.C, which encodes amino acids 443 to 1132 of Pfs230, was found to generate 
antibodies that significantly reduce parasite infectivity in the mosquito midgut (between 
71.2-89.8%) (Williamson et al., 1995). This region of Pfs230 contains twelve cysteines 
(Williamson et al., 1993) that in parasite-produced Pfs230 probably form distinct disulfide 
bonds which help define the conformation of the protein. Pfs230-specific monoclonal 
antibodies that have transmission-blocking activity only recognize non-reduced parasite-
produced Pfs230 (Quakyi et al., 1987) suggesting that the conformation of the monoclonal 
antibody epitopes in the native protein depends on disulfide bonds. Because recombinant 
Pfs230 was synthesized in the reduced cytosolic environment of E. coli, proper formation 
of these critical disulfide bonds may have been inhibited. This may explain why antisera 
against E. coli-produced Pfs230 region C (r230.MBP.C) did not completely block parasite 
infectivity. 
The purpose of this study was to express and characterize a region of Pfs230 (C-
Nterm) in Saccharomyces cerevisiae (S. cerevisiae). A yeast expression system has been 
previously shown to accurately recreate the conformation in another P. falciparum protein, 
Pfs25 (Kaslow and Shiloach, 1994). C-Nterm (amino acid 447 to amino acid 584 of 
Pfs230) encodes the amino terminus of Pfs230 region C which may the include the region 
of Pfs230 that is processed as the parasite emerges from the red blood cell. Additionally, 
C-Nterm is a small enough region of Pfs230.C to be expressed efficiently in a yeast 
expression system. 
Literature Review 
It is estimated that almost one half of the world's population is threatened by 
malaria (Saul, 1992; WHO, 1993). Present in over 100 countries, the disease, caused by 
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mosquito-borne parasites, is responsible for 300-500 million clinical cases annually 
(WHO, 1993). Approximately one to three million people die each year from malaria 
related illnesses and most of those are children (Hoffman and Miller, 1996). Malaiia 
continues to be a serious problem in the tropics because measures devised to control it, 
such as the use of anti-malarial drugs, larvicides, and insecticides have proven insufficient 
in eliminating the parasite and preventing its transmission to the mosquitoes (Hoffman and 
Miller, 1996). 
Human malaria is caused by four species of protozoan parasites of the genus 
Plasnwdium: P. falciparum, P. vivax, P. ovale, P. malariae (Oaks, 1991). Although P. 
vivax is responsible for causing the most infections worldwide, the most virulent of those 
parasites is P. falciparum (van Dijck et al., 1995). The parasites are transmitted to 
humans by a sub-group of 50-60 species of mosquitoes in the genus Anopheles (Oaks, 
1991). 
Malarial parasites were first seen in humans in 1880 (Review by Markell, 1992). 
Their development both in the anopheline mosquito and in the human bloodstream had 
been understood and the life cycle elucidated by the early 20th century (Review by 
Markell, 1992). Upon being bitten by an infected anopheline mosquito, the parasite is 
introduced into humans in the form of sporozoites (Oaks, 1991). Within forty minutes 
following injection into the human host sporozoites invade hepatocytes (Markell, 1992). 
During the following five to fifteen days the sporozoites develop into schizonts within the 
liver cells (Oaks, 1991). Each of these schizonts goes on to develop into 10,000 to 
30,000 merozoites (Oaks, 1991). After rupturing the infected hepatocytes, merozoites are 
released into the bloodstream where they are able to invade erythrocytes. Once in the 
erythrocyte merozoites begin to asexually reproduce. Within 48-72 hours each merozoite 
matures into a schizont containing eight to thirty-two new merozoites (Oaks, 1991). 
Eventually the infected red blood cells rupture releasing merozoites which are then free to 
infect other erythrocytes (Oaks, 1991). Rupturing of these red blood cells releases 
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parasite metabolites which are toxic and may contribute to the symptoms associated with 
malaria, such as fever (Markell, 1992). 
Some time after asexual parasites first appear in the bloodstream a subpopulation 
of merozoites differentiates into either male or female gametocytes. This form of the 
parasite grows within red blood cells but does not divide and matures to become the 
infectious form of the parasite. The trigger for the differentiation between the asexual and 
sexual life cycle is unknown (Markell, 1992). When an anopheline mosquito draws blood 
from an infected individual, red blood cells containing parasites (including gametocytes), 
as well as other serum components such as antibodies and complement, are taken up by 
the insect. The sexual stage of parasite development then proceeds in the midgut of the 
mosquito. 
Under the influence of a change in temperature and/or chemical environment, 
intraerythrocytic gametocytes taken up in a bloodmeal emerge from the red blood cells in 
the mosquito midgut minutes after ingestion (Carter, 1988a). Presumably due to some 
substance released by the gametocytes themselves, the host red blood cell membranes are 
disrupted and gametocytes become extracellular (Carter, 1988a). Shortly after emergence, 
male gametocytes differentiate into eight highly motile microgametes, a process known as 
exflagellation (Carter, 1988a). These microgametes then proceed to fertilize female 
gametes derived from corresponding gametocytes (Carter, 1988a). Fertilization is 
complete less than 30 minutes after the parasite is ingested by the mosquito (Carter, 
1988a). From the point of red blood cell emergence onward the parasite is extracellular 
and is therefore exposed to host components present in the bloodmeal such as 
complement, cytokines, and antibodies (Carter, 1988a). 
In the 12-48 hours following fertilization, a zygote transforms into an ookinete 
which penetrates the mosquito midgut wall to become an oocyst (Oaks, 1991). The 
oocyst continues to develop on the serosal surface of the midgut adjacent to the haemocoel 
(Carter, 1988a). This oocyst enlarges over time forming greater than 10,000 sporozoites. 
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After the oocyst ruptures, sporozoites are released and migrate to the salivary glands of the 
insect where they are ready to infect the next human, thus perpetuating the cycle of 
infection (Oaks, 1991). 
Because alternative measures to control or eradicate malaria have met with only 
limited success, the past two decades have focused on the development of antimalarial 
vaccines in attempt to control the disease worldwide. There are four major categories of 
vaccines classified according to the part of the parasite life cycle that they are designed to 
attack: 1) Pre-erythrocytic vaccines are aimed at preventing sporozoite invasion of liver 
cells and/or destroying parasite infectivity of hepatocytes; 2) Blood stage vaccines try to 
limit replication of erythrocytic stage parasites; 3) Anti-disease vaccines attempt to 
alleviate anemia, fevers, and other clinical illnesses associated with malaria; 4) 
Transmission-blocking vaccines are designed to prevent infected individuals from 
transmitting the parasite back to the mosquito thus halting the spread of the disease 
(Kaslow, 1993). Transmission-blocking vaccines, aimed at the sexual stage of parasite 
development, target either intraerythrocytic gametocytes in the vertebrate host or 
extracellular gametes that emerge in the insect (Kaslow, 1993). This type of vaccine will 
not necessarily protect already-infected individuals, but it may reduce the spread of malaria 
by slowing or halting the transmission of the parasite from the vector to the host (Oaks, 
1991). Most likely, transmission-blocking vaccines would be administered in conjunction 
with pre-erythrocytic and blood stage vaccines in attempt to combat malaria related 
illnesses (Oaks, 1991). A combination vaccine targeting more than one stage of parasite 
development would likely make it more difficult for the escape parasites to mutate in an 
attempt to evade immune responses. 
The earliest demonstration of transmission-blocking activity was in 1958 when 
Huff et al. immuniz.ed chickens with the avian parasite P. gallinaceum and noted that host 
factors (possibly antibodies) could decrease the relative infectiousness of gametocytes 
(Huff et al., 1958). Chickens were immunized with P. gallinaceum-infected, formalin 
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treated erythrocytes and two to three days later challenged with an infective inoculation of 
live gametocytes (Huff et al .. 1958). Experiments revealed that when mosquitoes took a 
bloodmeal from these immunized chickens there was a significant decrease in the ability of 
gametocytes to produce oocysts in the mosquito midgut (Huff et al., 1958). This evidence 
of transmission-blocking immunity was further supported in 1976 when Gwadz 
immunized chickens with an inactivated preparation of P. gallinaceum-infected red blood 
cells (Gwadz, 1976). Immunized chickens were infected and then Aedes aegypti 
mosquitoes were allowed to take a bloodmeal. P. gallinaceum infectivity in the mosquito 
was measured by counting the number of oocysts per midgut (Gwadz, 1976). In 
mosquitoes that ingested gametocytes from twice (or more) inoculated chickens infectivity 
was reduced 95-98% (Gwadz, 1976). It was noted however that by immunizing chickens 
there was little effect on asexual parasitemia and that immunization did not affect 
gametocyte production in the host (Gwadz, 1976). In follow-up studies, Carter and Chen 
used partially purified gametes to immunize chickens and found infectivity was further 
reduced to 99.9-100% (Carter and Chen, 1976; Carter et al., 1979). Again, asexual 
parasitemias in experimental animals correlated with the asexual parasitemias found in the 
controls (Carter and Chen, 1976; Carter et al., 1979). The study by Carter and Chen 
further noted that immunizations with partially purified preparations of both male and 
female gametes were more effective in reducing parasite infectivity to the mosquito than 
were single sex gamete preparations (Carter and Chen, 1976). 
While studies had shown that immunizing chickens with gametes resulted in a 
decrease in oocyst development in the mosquito (Gwadz, 1976; Carter and Chen, 1976; 
Carter et al., 1979) those same studies failed to indicate that any protection was being 
offered against the asexual stages of parasite infection. Subsequent studies with monkey 
and rodent malarias did show transmission-blocking immunity as well as protection 
against the asexual parasites (Gwadz and Green, 1978; Mendis and Targett, 1979). In a 
study by Gwadz and Green, rhesus monkeys were immunized with an antigen preparation 
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of asexual and sexual stage P. knowlesi parasites emulsified in Freund's Complete 
Adjuvant (FCA) (Gwadz and Green, 1978). After challenge with P. knowlesi, monkeys 
immunized with the antigen preparation and FCA were not infectious to feeding 
mosquitoes (Gwadz and Green, 1978). The authors of this study hypothesized that anti-
gamete antib~dies produced in the monkeys could have been responsible for blocking the 
sexual development of P. knowlesi in the mosquito (Gwadz and Green, 1978). This was 
illustrated by the fact that antisera from immunized monkeys showed complete 
transmission-blocking activity and had microgamete immobilizing activity (Gwadz and 
Green, 1978). Neither activity was evident in the controls (Gwadz and Green, 1978). In 
addition, immunized monkeys seemed to be protected against asexual parasites and had 
significantly reduced parasitemias and consequent pathology (Gwadz and Green, 1978). 
It was purported that suppression of asexual parasitemias could have been due to the 
asexual parasites used in the antigen preparation or due to antigens common to both 
asexual and sexual stages of the parasite (Gwadz and Green, 1978). In a similar study, 
Mendis and Targett showed that mice vaccinated with a crude preparation of P. yoelli-
forrnalin fixed gametes showed significantly reduced infectivity to mosquitoes and well as 
a pronounced (though not complete) immunity to the erythrocyte stage parasites (Mendis 
and Targett, 1979). Their study also showed that an effective block on transmission was 
possible without the use of an adjuvant. 
The first study to demonstrate a correlation between transmission-blocking 
immunity and anti-gamete antibodies in immune serum was performed by Gwadz et al. 
(Gwadz et al., 1979). For this study chickens and monkeys were used as the 
experimental models. Animals were immunized with preparations containing gametes of 
their respective malaria parasites, P. gallinaceum and P. knowlesi (Gwadz et al., 1979). 
Mosquito feeds and subsequent mosquito midgut oocyst counts showed that transmission-
blocking immunity was induced in the animals (Gwadz et al., 1979). In addition, it was 
shown that when parasitized blood from an immunized chicken or monkey was washed 
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free of its plasma and then resuspended in non-immunized serum the gametocytes 
recovered full infectivity to mosquitoes (Gwadz et al., 1979). Furthermore, when 
parasitized blood from non-immunized chickens was fed to mosquitoes in the presence of 
serum from immunized birds, infectivity to mosquitoes was completely suppressed 
(Gwadz et al., 1979). These results suggest that it is some serum component (i.e. 
antibodies) that mediates transmission-blocking immunity. Agglutination reactions and 
fluorescent antibody tests did indicate anti-gamete antibodies were present in the chicken 
and monkey serum (Gwadz et al., 1979). The presence of anti-gamete antibodies 
suggests that reduction in parasite infectivity was mediated by anti-gamete antibodies 
which were ingested in the mosquito bloodmeal (Gwadz et al., 1979). These antibodies 
have been shown to interact with extracellular gametes as they emerge from the red blood 
cells thereby preventing fertilization in the mosquito midgut (Gwadz et al., 1979). 
In transmission-blocking immunity, similar to vaccines against the asexual stage of 
parasite development, surface proteins are targeted. Most transmission-blocking research 
has focused on antigens present on the surface of parasites during the extracellular, sexual 
stage of development: namely, proteins on gametes, zygotes, and ookinetes (Oaks, 
1991). Three vaccine candidates that appear on the surface of gametes have been 
identified: Pfs230, Pfs48/45, and Pfs40/10. In addition, Pfs25, which is expressed at the 
late gamete/early zygote stage of development, and Pfs28, present on the ookinete surface, 
have also been identified. 
The focus of this research project was on Pf s230. Rener et al. were the first to 
indicate that Pfs230 was one of the target antigens for transmission-blocking immunity 
(Rener et al., 1983). The Rener et al. study showed that two monoclonal antibodies 
(monoclonal antibody IA3-B8 and monoclonal antibody IIC5-B10) acted synergistically to 
target the surface of P. falciparum strain 708 (a Brazilian isolate) (Rener et al., 1983). 
Together, but in the absence of complement, these two monoclonal antibodies mediated 
almost total suppression of infectivity to mosquitoes (Rener et al., 1983). In addition, 
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monoclonal antibody IA3-B8 alone, in the presence of activated complement, suppressed 
infectivity to mosquitoes by 90% (Rener et al., 1983). In the absence of complement 
either monoclonal antibody had slight effect in reducing infectivity, suggesting that the 
effects of monoclonal antibody IA3-B8 alone were complement mediated (Rener et al., 
1983). 
In contrast to the studies by Rener et al., a later study tested the ability of several 
monoclonal antibodies to block malaria transmission and found that only one of fifteen 
monoclonals developed, monoclonal antibody 28Fl, was monospecific for Pfs230 
(Vermeulen et al., 1985). Yet monoclonal antibody 28Fl failed to exhibit transmission-
blocking immunity (Vermeulen et al., 1985). Three other monoclonal antibodies which 
precipitated Pfs230, monoclonal antibody 29F432, monoclonal antibody 7F3, monoclonal 
antibody 32Fl and also antibody 1771 (rabbit polyclonal antibodies), always did so in 
conjuction with Pfs48/45 (Vermeulen et al., 1985). The fact that Pfs230 and Pfs48/45 
coprecipitated might suggest that these proteins are interrelated and possibly possess a 
common antigenic site (Vermeulen et al., 1985). Alternative possibilities may be that 
Pfs230 and Pfs48/45 interact by coprecipitating nonspecifically or that they form a 
complex on the surface of the parasite. The monoclonal antibodies that coprecipitate 
Pfs230 (monoclonal antibody 29F432, monoclonal antibody 7F3 and monoclonal 
antibody 32Fl) always bound significantly more Pfs48/45 (Vermeulen et al., 1985). 
Additionally, a positive reaction to Pfs230 could never be detected with monoclonal 
antibody 29F432, monoclonal antibody 7F3, monoclonal antibody 32Fl, or rabbit 
polyclonal antibodies (Vermeulen et al., 1985). This may lend support to the theory that 
Pfs230 coprecipitates with Pfs48/45 nonspecifically or forms a complex with Pfs48/45. 
The Vermeulen et al. study further showed that monoclonal antibody 32F3 and 
monoclonal antibody 32F5, which specifically precipitate Pfs48/45, most effectively 
blocked oocyst formation in the mosquito. The authors therefore concluded that Pfs48/45 
was a good transmission-blocking vaccine candidate. The authors further suggested that 
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Pfs230 merely coprecipitated with Pfs48/45 and probably was not a transmission-blocking 
vaccine candidate antigen (Vermeulen et al., 1985). 
A study by Quakyi et al. however reestablished Pfs230 as a transmission-blqcking 
vaccine candidate showing that it alone was the target of two transmission-blocking 
monoclonal antibodies, 1B3 and 2B4 (Quakyi et al., 1987). Pfs230 was also 
immunoprecipitated by monoclonal antibody IIC5-B10, rabbit serum raised against whole 
gametes, and rabbit serum raised against purified Pfs230 (Quakyi et al., 1987). In the 
presence of complement, monoclonal antibody 1B3 and monoclonal antibody 2B4 
suppressed infectivity of P. falciparum 3D7 (an Amsterdam isolate) to mosquitoes by 95-
100% (Quakyi et al., 1987). Neither monoclonal antibody suppressed infectivity when 
complement was heat inactivated, suggesting that monoclonal antibody 1B3 and 
monoclonal antibody 2B4 were complement dependent (Quakyi et al., 1987). In addition, 
monoclonal antibody 1B3 and monoclonal antibody 2B4 only reacted with Pfs230 under 
reducing conditions suggesting that the conformation of the epitopes recognized by 
monoclonal antibodies were defined by disulfide bonds (Quakyi et al., 1987). A follow-
up study reported that the epitopes defined by monoclonal antibody 1B3 and monoclonal 
antibody 2B4 were generally well conserved among 45 isolates examined by 
immunofluorescence assay (Foo et al., 1991). This relative absence of antigenic diversity 
of Pfs230 among different strains of P. falciparum is promising for transmission-blocking 
vaccine development as the vaccine would probably be effective against most isolates. 
Field studies have indicated that Pfs230 is a good transmission-blocking vaccine 
candidate and is naturally immunogenic (Graves et al., 1988; Carter et al., 1988b; 
Premawansa et al., 1994; Riley et al., 1994). Trials done in Papua New Guinea evaluated 
serum from adults living in this malaria endemic area and found that antibodies against 
Pfs230 correlated with the ability of the serum to block malaria transmission (Graves et 
al., 1988). Individuals in the study had all been exposed to multiple reinfections (Graves 
et al., 1988). Naturally occurring antibodies to Pfs48/45 were found in the Papua New 
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Guinea sera but they did not directly correlate with a decrease in parasite infectivity of the 
mosquito midgut (Graves et al., 1988). In contrast to the Graves et al. study. a recent 
study in Sri Lanka, an area of lower malaria transmission, has shown that followipg an 
acute primary infection, antibodies against Pfs230 did not correlate with anti-parasite 
activity (Premawansa et al., 1994). Considering the results of both studies it is possible 
that perhaps only repeated challenges with malarial infection lead to a maturation of 
transmission-blocking immune response (Premawansa et al., 1994). 
In addition to the aforementioned studies Read et al. have identified sixteen 
monoclonal antibodies which specifically recognize Pfs230 under non-reducing conditions 
and define nine distinct epitopes of the protein (Read et al., 1994). These same sixteen 
monoclonal antibodies failed to react with Pfs230 when the antigens were treated with ~­
mercaptoethanol, suggesting that Pfs230 monoclonal antibodies were conformation 
dependent (Read et al., 1994). This evidence of reduction sensitive antibodies upheld a 
previous study by Quakyi et al. Eight of the monoclonal antibodies in Read's study of the 
IgG2a isotype mediated complement dependent lysis of gametes (Read et al., 1994). 
Seven other monoclonal antibodies of murine immunoglobulin isotype IgG1 (which do not 
fix complement) failed to lyse gametes. This suggested, as Quakyi et al. did before, that 
anti-Pfs230 antibodies are complement dependent (Quakyi et al., 1987; Read et al., 1994). 
Because Pfs230 can elicit an immune response during a natural infection, it may be 
that an immune response to a subunit vaccine could be boosted during a natural infection 
in humans (Hoffman and Miller, 1996). This maybe important for inducing long lasting 
immunity. This could also give a Pfs230 vaccine an advantage over other transmission-
blocking candidate antigens (i.e. Pfs25) which do not elicit immune responses upon 
natural infection (Kaslow, 1993). 
Pfs230 was cloned and sequenced from both the 3D7 (derived from NF54 
Amsterdam Airport isolate) and the 7G8 (derived from a Brazilian isolate) P. falciparum 
strains (Williamson et al., 1993). The gene encodes a 363 kDa protein. There are a 
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number of distinct physical properties associated with the protein. Pfs230 has three 
regions of highly net negative charge across the protein which includes the 25 contiguous 
glutamine (E) residues and sixteen tandem E-E/G-V /E-G repeats located at the amino 
terminus of the molecule (Figure 1). The charged regions of the surface protein are 
speculated to act as a shield for the parasite by protecting it with an electrostatic field 
thereby preventing aggregation by repulsion (Williamson et al., 1993). The remainder of 
the molecule contains seven cysteine motifs which are presumably involved in the tertiary 
structure of Pfs230 (Figure 1) (Williamson et al., 1993; Carter et al., 1995). 
Pfs230 is present on gametocytes prior to gamete development in the mosquito 
midgut and is therefore present in the human host (Kumar and Carter, 1984). It was 
found that Pfs230 protein expression is localized to the parasite plasma membrane in both 
gametocytes and gametes (Williamson et al., 1996). The protein is synthesized on day 
two of gametocytogenesis (Vermeulen et al., 1986). Recently it was demonstrated that the 
360 kDa form of the molecule is processed to a smaller, 310 kDa protein at a time which 
corresponds to gamete emergence from the red blood cells (Williamson et al., 1996). 
The physical properties of Pfs230 may be linked to immune evasion strategies by 
the parasite (Williamson et al., 1996). Recall that in humans Pfs230 is expressed by 
intraerythrocytic gametocytes as a 360 kDa protein containing numerous E-E/G-V/E-G 
repeats (Figure 1). It is often the case that repeat regions such as these are 
immunodominant because many copies of the same sequence often increase the avidity for 
antibodies (Kemp et al., 1987). Although circulating parasites are hidden in host red 
blood cells there is evidence that a host immune response can be generated to Pfs230 upon 
a natural infection (Graves et al., 1988; Carter et al., 1988b). This is probably due to 
parasitized red blood cells that are cleared by the spleen and then presented to the immune 
system (Carter, 1988a; Carter, 1988b). Because much of the antibody response generated 
in malaria infections is directed toward repeat epitopes (Kemp et al., 1987), an immune 
response would probably be directed towards the repeat epitopes in the amino terminal 50 
Pfs230 





m4 lf.1 m5 :-:=Ill m6 m7 
S=secretory signal sequence 
E=25 glutamates 
R=E-E/G-V/E-G repeats 
m=original cysteine motifs 
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Figure 1. Schematic of Pfs230. The unique physical properties of Pfs230 include the 
stretch of glutamates and the E-E/G-V/E-G repeats near the amino terminus of the full 
length 360 kDa protein. In addition, the molecule contains seven cysteine motifs which 
are likely involved in the tertiary structure of the protein. 
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kDa of Pfs230, the region which is shed upon parasite emergence from the red blood cell. 
If the first 50 kDa were targeted by host antibodies, these antibodies would be present in a 
bloodmeal and the parasite would become exposed to the antibodies in the mosquito 
midgut. By shedding the amino terminal 50 kDa of the protein, parasites evade an 
immune response and cannot be recognized by antibodies directed towards the repeat 
region (Williamson et al., 1995). This strategy-of-evasion theory is supported by studies 
that suggest that the most immunoreactive regions of recombinant Pfs230 proteins are 
amino acids which encode the (E-E/G-E/V-G)n repeats within the first 50 kDa of Pfs230 
(Riley et al., 1995). 
A recent study reported the production of six recombinant Pf s230 proteins which 
were produced in E. coli as fusions with MBP (Williamson et al., 1995). These 
recombinants, which encoded 83% of Pfs230, were labeled r230.MBP.A-r230.MBP.F. 
The immunogenicity of these recombinants was tested in mice (Williamson et al., 1995). 
One region, r230.MBP.C (Figure 1), induced antibodies that significantly reduced parasite 
infectivity (71.2-89.8%) in the mosquito midgut (Williamson et al., 1995). r230.MBP.C 
encodes amino acid 443 to amino acid 1132 of Pfs230. This is the region immediately 
following the E-E/G-E/V-G repeats and includes the first cysteine motif. The initial 
recombinants were produced in the reduced cytosolic environment of E. coli, not the 
secretory pathway of a eukaryote, and thus disulfide bonds may have formed randomly 
during the preparation or purification of Pfs230 region C as an antigen. If Pfs230 region 
C was expressed in heterogeneous conformations in E. coli, crucial epitopes within that 
region may or may not have been formed as they are in parasite-produced Pf s230. This 
would result in some antisera that recognizes parasite-produced Pfs230 and some that does 
not. Accordingly, only a subpopulation of the antibodies produced may effectively block 
transmission. Thus to further evaluate the ability of region C to induce transmission-
blocking immunity it is necessary to express this region in other systems such as yeast or 
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mammalian cells which target the recombinants to a secretory pathway and permit correct 
disulfide bond formation. 
The objective of this project was to express region C-Ntenn of Pfs230 (amino acid 
447 to amino acid 584) in yeast. This portion of the molecule is important for two 
reasons. C-Nterm is a small part of Pfs230 region C, a region which has been previously 
shown to generate antibodies that reduce P. falciparum transmission to mosquitoes. In 
addition, C-Nterm is a small enough region to be expressed efficiently in yeast. The yeast 
expressed C-Nterm protein could later be tested for its ability to induce antibodies that 
decrease parasite infectivity in the mosquito midgut. If yeast expressed C-Nterm is a more 
potent immunogen than E. coli-produced r230.MBP.C, vaccine efforts may be focused on 
yeast produced C-Nterm. Furthermore, future experiments could be done with C-Nterm 
protein to determine if it encodes the precise region where stage-specific processing of 
Pfs230 occurs. This may lead to further insight into parasite immune evasion strategies. 
S. cerevisiae, or baker's yeast, has been the first choice of many investigators to 
supplement prokaryotes in the production of recombinant proteins. The major reasons a 
yeast expression system was chosen for this project is because it offers high protein yield 
as well as the possibility of inexpensively scaling up production of protein for a vaccine. 
In addition, yeast have been shown to produce other recombinant P. falciparum proteins, 
such as Pfs25 and MSAl, in high yield (Kaslow and Shiloach, 1994; Hui et al., 1994). 
Also, the extensive secretory pathway yeast proteins undergo will likely yield a more 
properly conformed protein than E.coli did (Gellissen, 1992). This may be of particular 
importance for a Pfs230 vaccine since it has been shown that transmission-blocking 
monoclonal antibodies which recognize the molecule are conformation dependent (Quakyi 
et al., 1987; Read et al., 1994). 
The secretory pathway in eukaryotes has been firmly established. Polypeptides 
with hydrophobic amino terminal regions, like the a signal sequence in S. cerevisiae, can 
be targeted for secretion through the rough endoplasmic reticulum (Alberts et al., 1994). 
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The signal sequence targets the protein for production/translation in the rough endoplasmic 
reticulum by binding to the signal-recognition particle (SRP) complex (Alberts et al.. 
1994). One end of the SRP complex binds to the signal sequence while the other end 
binds to the ribosome (Alberts et al., 1994). This step causes a temporary pause in 
translation to prevent the protein from being released into the cytosol (Alberts et al., 
1994). Once formed, the SRP ribosome complex then binds to the SRP receptor in the 
rough endoplasmic reticulum membrane and translation continues (Alberts et al., 1994). 
The polypeptide is then translocated across the rough endoplasmic reticulum where the 
signal sequence is cleaved by a membrane bound protease (Tuite and Oliver, 1991). Once 
in the rough endoplasmic reticulum, resident chaperones and isomerases may bind to the 
nascent polypeptide chain and regulate folding, disulfide bond formation, and 
posttranslational modification. After translation, the protein is delivered to the Golgi for 
further processing and then the protein can be shuttled via secretory vesicles to the 
extracellular space. 
Posttranslational modification of yeast proteins begins in the rough endoplasmic 
reticulum. While N-linked glycosylation, a frequent form of posttranslational modification 
in yeast, is initiated in the rough endoplasmic reticulum, the extension of oligosaccharide 
side chains occurs in the Golgi apparatus. Fully glycosylated proteins are then transported 
to the plasma membrane and the contents are discharged (Tuite and Oliver, 1991). 
Glycosylation can occur in one of two ways: N-linked glycosylation occurs at asparagine 
residues in the sequence asn-X-ser/thr where Xis any amino acid except proline; 0-linked 
glycosylation occurs at serine or threonine residues. While C-Nterm lacks the requisite 
sequence for N-linked glycosylation, there are thirteen serines and seven threonines in 
Pfs230.C-Nterm, leaving C-Nterm sensitive to 0-linked glycosylation. In yeast, 0-linked 
glycosylation exclusively involves the addition of mannoses directly to serines or 
threonines usually in chains of 5 or less (Tanner and Lehle, 1987). 
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Another posttranslational modification carried out by yeast which can alter protein 
structure includes phosphorylation, which involves the addition of phosphates to the 
hydroxyl groups of serine, threonine or tyrosine residues (Alberts et al., 1994). 
Sulfation, also a posttranslational modification, occurs primarily at tyrosine residues in 
secretory proteins (Han and Martinage, 1992). In addition to the many serines and 
threonines in C-Nterm, this region of Pfs230 also contains eight tyrosines. One other type 
of posttranslational modification is fatty acylation (the addition of hydrophobic acid groups 
to proteins). Isoprenylation is the addition of a 15 carbon fatty acid (farnesylation) or 20 
carbon fatty acid (geranylgeranylation) to the carboxy terminus of proteins (Caldwell et 
al., 1995). Palmitoylation is also a type of fatty acylation which involves the addition of a 
16 carbon chain to cysteine residues throughout the length of polypeptides. 
Myristoylation, which occurs cotranslationally, is the attachment of a 14 carbon chain to 
the amino terminus of a protein (Schafer and Rine, 1992). Most reports have these fatty 
acid additions occurring in the cytosol (Alberts et al., 1994) and are therefore unlikely to 
appear on a yeast secreted recombinant protein. 
Experimental Design 
CHAPTER II 
MATERIALS AND METHODS 
A previous study showed that antisera to an E. coli-produced recombinant of 
Pfs230, r230.MBP.C (encoding amino acid 443 to amino acid 1132), decreased parasite 
infectivity in the mosquito midgut by 71.2-89.8% (Williamson et al., 1995 ). This project 
concentrated on generating S. cerevisiae-produced recombinant Pfs230 which can be used 
in future studies to test for its ability to induce complete malaria transmission-blocking 
immunity. To do this, mice will be vaccinated with yeast produced Pfs230.C-Nterm. The 
antisera generated will then be used to test for decreased parasite inf ectivity in the 
mosquito midgut. 
The expression vector used in this study was the Yeast N-Terminal Flag 
Expression Vector (YEp) (Eastman Kodak Company, New Haven, CT). YEp is a 7205 
base pair plasmid with a multiple cloning site (MCS) region. An fl origin of replication 
allows this vector to replicate in E. coli and a selectable marker is provided by the 
ampicillin resistance gene. A two micron circle element and a tryptophan (TRP) selectable 
marker are encoded in the vector for growth and selection in yeast. The vector was 
modified to encode a six histidine tag at the 3' end of the multiple cloning site to provide a 
means of purifying the recombinant protein. To express the amino terminus of Pfs230 
region C (amino acid 447 to amino acid 584) the nucleotide sequence was amplified via the 
polymerase chain reaction (PCR). The resultant PCR product and the modified yeast 
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expression vector (m YEp) were digested with compatible restriction endonucleases and 
ligated together. E.coli was transfected with this plasmid construct (C-Ntenn/mYEp) via 
electroporation. Transfected bacterial colonies were grown on solid media, selected, 
amplified in liquid media, harvested, and the construct recovered. The isolated plasmid 
construct was transfected into yeast, S. cerevisiae. Yeast colonies that grew in the absence 
of tryptophan (TRP) were selected and then grown in a medium conducive to protein 
expression. After the protein was expressed it was purified and characterized to determine 
if it was recombinant Pfs230.C-Nterm. 
Reagents 
Unless otherwise indicated, chemicals were purchased from Sigma Chemical 
Company, St. Louis, MO and restriction endonucleases and DNA-modifying enzymes 
were purchased from Life Technologies, Gaithersburg, MD. 
Transformation of E. coli with YEp Plasmid 
Luria-Bertani (LB) medium [l % (w/v) Bacto-tryptone (Difeo Laboratories, 
Detroit, Ml); 0.5% (w/v) Bacto-yeast extract (Difeo Laboratories, Detroit, Ml); 1 % (w/v) 
NaCl (Brown, 1991)] was inoculated with JM109 E. coli cells from a glycerol stock 
(Promega Corporation, Madison, WI) and then incubated at 37°C, 250 rpm (Lab-Line 
Instruments, Melrose Park, IL) for 48 hours. A 300 µl aliquot of the saturated culture 
was added to 50 ml fresh LB and grown at 35.5°C, 240 rpm to an OD600 of 0.58. 
The cells were harvested (2420 x g, five minutes, 4°C) and the supernatant was 
quickly decanted. The cell pellet was resuspended in ice cold sterile 20 mM Na Cl and 
centrifuged (2420 x g, five minutes, 4°C). The supernatant was removed and cells were 
resuspended in 0.4M CaC12 and centrifuged (2420 x g, five minutes, 4°C). After quickly 
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decanting the supernatant, cells were resuspended in the following solution which was 
made and filter-sterilized immediately prior to use: 0.056 M MnC12 , 0.04 M CaCl2 , 
0.032 M ammonium acetate. The resulting calcium competent JM109 E. coli was then 
incubated on ice for 20 minutes. 
Five ng of Yeast N-Terminal Flag Expression Vector (YEp) was added to 200 µl 
of calcium competent JM109 cells. To another 200 µl of the calcium competent JM109 
cells 50 ng of YEp was added. Both mixtures were incubated on ice for one hour. The 
cells were then heat shocked in a 42°C water bath for two minutes (to allow incorporation 
of the YEp vector into cells) and placed on ice for two minutes. To the cells, 800 µl of 
SOC medium [2% Bacto-tryptone; 0.5% Bacto-yeast extract; 0.05% NaCl; 20 mM 
glucose (Sambrook et al., 1989)] was added. Cells were incubated at 37°C for 30 minutes 
at 250 rpm and then streaked onto LB/agar plates containing 100 µg/ml of the antibiotic 
ampicillin. Only cells transformed with the YEp vector (which contains the ampicillin 
resistance gene) can survive in this medium. After incubating upright at room temperature 
for five minutes, the plates were inverted and placed at 37°C overnight. 
The next day, six tubes each containing 5 ml of liquid LB/ampicillin (100 µg/ml) 
were inoculated separately with six bacteria colonies from the plates. The liquid cultures 
were grown in a 37°C shaking incubator at 250 rpm overnight. The following day, 
cultures were removed from the shaker and placed at 4°C for seven hours. An 800 µl 
aliquot of cells was removed from each culture then gently vortexed with 200 µl of 
glycerol and stored at -70°C as a renewable glycerol stock of the YEp vector. The 
remaining cells were harvested by centrifugation (16,000 x g, two minutes) and the 
supernatants were decanted. The pellets (to be used later for isolating plasmid) were 
stored at -20°C. 
21 
YEp Plasmid Preparation (Minipreps) 
To recover the YEp plasmid from the transfected JM109 E. coli, Wizard™ 
Minipreps (Promega Corporation, Madison, WI) were performed. Briefly, bacterial 
pellets from the six overnight cultures were lysed under alkaline conditions. The lysates 
were then neutralized causing the E. coli plasma membrane and attached genomic DNA to 
precipitate. The precipitated material was pelleted and the supernatants containing the 
plasmid DNA were recovered. To isolate the plasmid DNA from the supernatants, a 
silica-based resin was added. After the resins were washed in high salt to remove 
unbound contaminants, bound DNA was eluted in low salt Tris.IEDTA (TE) buff er [ 10 
mM Tris-HCl; 1 mM EDTA, pH 8.0 (Brown, 1991)] and was stored at -20°C. Reference 
the 1994 Promega Technical Bulletin, Wizard™ Minipreps DNA Purification Systems for 
the detailed protocol (Promega Corporation, Madison, WI). 
Restriction Endonuclease Di~estion of YEp Plasmid 
To confirm that plasmid had been isolated from the bacteria, an aliquot of the 
purified plasmid from each of the six YEp minipreps was digested with restriction 
endonucleases and visualized on an agaroseffris-acetate/EDT A (T AE) [ 40 mM Tris-
acetate; 1 mM EDTA (Brown, 1991)] gel. Approximately 100 ng of purified YEp vector 
was digested with 5 units Kpn I in Buffer A [Cp= 6 mM Tris-HCl, pH 7.5; 6 mM MgC12; 
6 mM NaCl; 1 mM DTI (Promega Corporation, Madison, WI)] for a final reaction 
volume of 20 µL After a one hour incubation at 37°C concentrated (6X) DNA loading 
buffer was added to each sample for a final concentration of lX [0.042% bromophenol 
blue; 0.042% xylene cyanol FF; 6.67% (w/v) sucrose in water (Sambrook et al., 1989)]. 
The digests were evaluated by size fractionation via electrophoresis on a 0.8% 
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agaroseffAE gel containing 0.04 µg/ml of ethidium bromide. The gel was run at 100 V 
for 60 minutes and the DNA was visualized using an ultraviolet transilluminator. 
YEp Plasmid Modification 
1. Oligonucleotide CYEpH6SWYEpH6AII) Design and Kinasing Reactions. To 
provide an efficient means of protein purification, an oligonucleotide encoding a six 
histidine tag was designed to be incorporated into YEp. The sequence of the 
oligonucleotides (which also encoded an Nhe I restriction site) follows: 
Sense strand (YEpH6SII): 
5' C/GTC/GAC/CAC/CAC/CAC/CAC/CAC/CAC/TAG/GCT/ AGC/CCG/C 3' 
Antisense strand (YEpH6AII): 
5' GG/GCT/ AGCICTNGTG/GTG/GTGIGTG/GTG/GTG/GTCIGAC/GGG/CC 3' 
To prepare the oligonucleotides for a ligation reaction, a phosphate was added to the 5' -
hydroxyl terminus of each oligonucleotide using T4 Polynucleotide Kinase (T4 PNK). 
The reaction conditions follow: 
Kinasing reaction 
3 µg YEpH6SII or YEpH6AII 
30 Units T4 PNK 
70 mM Tris-HCl, pH 7.6 
10mMMgC12 
5mMDTT 
1.67 mM y 32P-ATP 
This reaction was incubated at 37°C for 30 minutes followed by a 10 minute incubation at 
65°C to inactivate the T4 PNK. The two phosphorylated oligonucleotides were 
subsequently annealed by the following reaction: 
Annealing oligonucleotides 
200 ng phosphorylated YEpH6SII 
200 ng phosphorylatcd YEpH6AII 




This mixture was first incubated in a 65°C heat block for two minutes then cooled slowly 
to 37°C (to allow annealing) by placing the heat block on the lab bench. 
2. Restriction Endonuclease Digestion of YEp Plasmid. To prepare the purified 
YEp plasmid for ligation, 800 ng of the purified DNA was digested with 10 u,nits of Apa I 
in Buffer A (Promega Corporation, Madison, WI) for a total reaction volume of 40 µl. 
After incubating for 1 hour at 37°C in a heat block 10 units of Sst II were added to the 
digestion and the reaction continued at 37°C for an additional two and one half hours. To 
stop the reaction concentrated ( 6X) DNA loading buffer was added to the sample for a 
final concentration of lX. The digest was evaluated by size fractionation via 
electrophoresis on a 0.8% agarosefTAE gel containing 0.04 µg/ml of ethidium bromide. 
The gel was run at 100 V for 60 minutes and the DNA was visualized using an ultraviolet 
transilluminator. 
3. Purification of Digested YEp Plasmid from Agarose CGeneclean™). The 
double digested YEp band was excised from the agaroseff AE gel and the DNA was 
recovered using the Geneclean™ Kit (BiolOl, LaJolla, CA). Briefly, 800 µl of 6 M Nal 
was added to the excised band and the mixture was incubated at 37°C for five minutes to 
dissolve the agarose. GLASSMILK™ was added to the tube and after five minutes, the 
GLASSMILK™/DNA complex was pelleted by centrifugation (16,000 x g, five seconds). 
The supernatant was decanted and the pellet was washed three times with ice cold NEW 
WASH™(BiolOl, LaJolla, CA). The pellet was desiccated for ten minutes and the DNA 
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was eluted twice using 12.5 µl of 1E buffer per elution. The genecleaned product was 
stored at -20°C. 
4. Li~ation YEpH611/YEp. The purified, double digested YEp plasmid was 
centrifuged (16,000 x g, 30 seconds) to pellet any residual GLASSMILK™. A 12.5 µl 
aliquot was taken from the top of the tube and added to the ligation reaction (described 
below) containing the annealed YEpH611 oligonucleotide. 
Li~ation reaction 
-200 ng genecleaned, Apa l/Sst II digested YEp 
-100 ng annealed YEpH611 oligonucleotide 
62.5 mM Tris-HCl, pH 7.6 
12.5 mM MgC!i 
1.25mMATP 
1.25mMDTT 
25% (w/v) polyethylene glycol-8000 
1 unit Ligase 
This reaction proceeded for four hours at room temperature. 
5. Transformation of E.coli with YEpH611/YEp (mYEp). ElectroMAX DHIOB™ 
E. coli cells (Life Technologies, Gaithersburg, MD) were transfected with the 
YEpH611/YEp ligation mix via electroporation. Electroporation is a technique which 
transiently permeabilizes bacteria cell membranes allowing foreign DNA to enter the cells. 
The ligation reaction was diluted 1:5 in distilled/deionized (dd) H20 and 1 µl (3 ng) 
of the diluted YEpH611/YEp ligation reaction was added to 40 µl of thawed DHlOB™ 
cells. As a positive control, 1 µl (0.01 ng) of pUC19 DNA (Life Technologies, 
Gaithersburg, MD) was placed in a tube with 40 µl of cells. The ligation reaction/cell 
mixture was added to chilled 1 mm gap micro-electroporation cuvettes (BTX Inc., San 
Diego, CA) and electroporated at 1.8 kV/cm with a time constant of 4.1 msec in the Gene 
Pulser II electroporator (Bio-Rad Laboratories, Hercules, CA). One ml of SOC medium 
was immediately added to the cells and the culture incubated in a 3 7°C shaking incubator 
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for one hour at 250 rpm. The cells were distributed onto two LB/ampicillin agar plates 
(500 µl per plate) and after one hour at room temperature the plates were inverted and 
incubated overnight at 37°C. The same procedure was repeated for the positive control 
pUC19 DNA. 
Six colonies were selected from the YEpH6SII/YEp plates and were grown in 
LB/ampicillin liquid media at 37°C, 250 rpm overnight. Plasmid DNA was isolated from 
the overnight cultures (Wizard™ Miniprep) and screened for the presence of the YEpH6II 
oligonucleotide by restriction analysis with Nhe I. Only the vectors which were modified 
with the YEpH6II oligonucleotide (mYEp) could be linearized by a Nhe I digest, because 
the oligonucleotide (and not the original YEp vector) encodes the Nhe I restriction site. 
Approximately 200 ng of one of the Wizard™ purified plasmids was digested at 37°C for 
one hour with 7.5 units of Nhe I in React 4 buffer [CF= 2 mM Tris-HCl, pH 7.4; 0.5 mM 
MgC~; 5 mM KCl]. The YEpH6SII/YEp digest was electrophoresed on a 0.8% 
agarose/TAE gel containing 0.01 µg/ml ethidium bromide and visualized on an ultraviolet 
transilluminator. As a negative control, approximately 200 ng of YEp vector was digested 
with Nhe I as per the above reaction conditions and was electrophoresed on the 0.8% 
agarose/T AE gel with the YEpH6SII/YEp digest. As additional controls, approximately 
200 ng of undigested YEp and YEpH6SII/YEp were subjected to the above reaction 
conditions (with the exception of Nhe I) and size fractionated on the same gel. 
Colonies that contained the YEpH6II oligonucleotide ligated into YEp (m YEp) 
were amplified in LB/ampicillin liquid media at 37°C, 250 rpm overnight. Following the 
overnight incubation glycerol stocks were made for storage at -70°C. The remaining 
culture was used to isolate the plasmid. 
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Construction of Pfs230.C-Nterm Expression Vector 
1. DNA Amplification Pfs230.C-Nterm. The polymerase chain reaction (_PCR) 
was used to amplify Pfs230 region C-Nterm base pair #1339 to base pair #1752 (which 
encodes amino acid 447 to amino acid 584) from P. falciparum genomic DNA (3D7 
strain). Synthetic oligonucleotides that corresponded to the following base pairs in Pfs230 
were used as primers in the reaction: sense oligonucleotide - base pair #1339 to base pair 
#1351; antisense oligonucleotide- base pair#l719 to base pair#l752. The 5' end of the 
sense oligonucleotide primer contained the sequence for the restriction enzyme Xho I, 
while the 5' end of the antisense oligonucleotide primer encoded the sequence for the 
restriction enzyme Apa I. These restriction enzyme sites were included to facilitate ligation 
into the multiple cloning site of m YEp. 
For PCR amplification, HotStart 50 tubes (Molecular-Bio Products Inc., San 
Diego, CA) containing wax beads were used. The wax served to separate upper and 
lower layer components until the reaction had begun and to prevent evaporation during the 
reaction cycles. Lower layer components of the reaction were added to the tube in the 
following proportions : 




10 mM Tris-HCl, pH 9.0 (at 25°C) 
1% TritonX-100 
600 ng sense primer 
600 ng antisense primer 
Reaction tubes were incubated in a thermocycler (MJ Research Inc., Watertown, MA) at 
90°C for 30 seconds then cooled to 4°C for five minutes to melt the wax bead over the 
lower layer. Upper layer components were then added to the reaction tube as follows: 
Upper layer components 
-1 µg 3D7 P. falciparum genomic DNA 
2mMMgC~ 
50mMKCl 
10 mM Tris-HCl, pH 9.0 (at 25°C) 
1 % Triton X-100 
5 units Taq polymerase 
27 
Initially, the reaction tubes were sequentially incubated (94°C for one minute; 38°C for 30 
seconds; 72°C for two minutes) to initiate the mixing of the reaction components. The 
PCR was then begun using the following program: 
PCR Reaction 
(A) INITIAL DENATURATION -- 94°C for 30 seconds 
(B) ANNEALING OF PRIMERS -- 38°C for 30 seconds 
(C) EXTENSION OF PRIMERS -- 72°C for 2 minutes 
(D) REPEAT STEPS A-C -- 30 cycles 
(E) FINAL EXTENSION OF PCR PRODUCTS -- 72°C for 6 minutes 
The size of the PCR amplified DNA was evaluated via electrophoresis on a 1.2% 
agaroseffAE gel containing 0.07 µg/ml ethidium bromide. DNA loading buffer was 
added to 2 µl samples of the PCR reaction. The gel was electrophoresed at 100 V for 60 
minutes and DNA was visualized using an ultraviolet transilluminator. 
The remaining PCR product was concentrated by ethanol (EtOH) precipitation. 
Briefly, 5 M ammonium acetate was added to the PCR sample to a final concentration of 
2.5 M. Ninety-five percent EtOH was added to the PCR amplified DNA to a final 
concentration of 63.33%. The sample was then incubated at 4°C for 48 hours, then 
centrifuged (16,000 x g, 20 minutes) and the supernatant decanted. The pellet was then 
dried and washed with 100 µl of 95% EtOH and centrifuged (16,000 x g) for an additional 
ten minutes. The supernatant was removed and the C-Nterm pellet was vacuum dried for 
three minutes and stored at -20°C until use. 
2. Restriction Endonuclease Digestion of C-Nterm and mYEp. The amplified C-
Nterm pellet was digested with restriction endonucleases to generate compatible ends for 
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ligation into mYEp. The estimated 5 µg C-Nterm pellet was resuspended in React 2 buffer 
[CF= 5 mM Tris-HCI, pH 8.0; 1 mM MgC12; 5 mM NaCIJ and 25 units of Xlw l 
(Promega Corporation, Madison, WI) were added to start the reaction. The reaction was 
incubated at 37°C for one hour and 15 minutes then EtOH precipitated (as described 
previously) using 5 M ammonium acetate and 95% EtOH. The Xho I-digested C-Nterm 
pellet was then resuspended in React 4 buff er and 25 units of Apa I were added to begin 
the second digestion. This reaction was incubated at 37°C for one hour and DNA loading 
buffer was added to stop the reaction. 
m YEp was isolated from an overnight culture of bacterial cells transfected with the 
mYEp plasmid using the QIAprep Spin Plasmid Miniprep Kit (50) (Qiagen Inc., 
Chatsworth, CA). Briefly, bacterial cells were lysed in NaOH/sodium dodecyl sulfate 
(SDS) in the presence of RNase. The salt concentration of the cell lysate was then 
increased, causing chromosomal DNA to precipitate. Genomic DNA was removed by 
centrifugation and the cleared supernatant was loaded onto a QIAprep spin column which 
has a silica based membrane that selectively adsorbs DNA After washing the QIAprep 
spin column, the m YEp DNA was eluted with 50 µl TE buffer. 
Qiagen purified mYEp (-500 ng) was digested with 10 units of Xho I in React 2 
buffer for one hour at 37°C. The DNA was then EtOH precipitated using 5 M ammonium 
acetate and 95% EtOH. The resultant Xho I-digested m YEp pellet was resuspended in 
React 4 buffer and 10 units of Apa I and then incubated for one hour and 20 minutes at 
37°C. The reaction was stopped by the addition of DNA loading buffer to the sample. 
The C-Nterm and mYEp samples were electrophoresed on a 1.2% agaroseffAE gel 
containing 0.04 µg/ml ethidium bromide for one hour at 114 V. The gel was visualized on 
an ultraviolet transilluminator for a very short time and the bands representing digested C-
Nterm and digested m YEp were excised. The digested DNA was extracted from the 
agarose and purified using the Geneclean™ Kit (BiolOl, LaJolla, CA) as described in the 
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YEp plasmid modification section of this chapter. The genecleaned products were stored 
at -20°C. 
3. Ligation C-Nterm/mYEp. Because both C-Nterm and mYEp were digested 
with the same restriction endonucleases, it was possible to perform a compatible end 
ligation reaction. The reaction conditions follow: 
Ligation reaction 
-180ng mYEp 
-48 ng C-Nterm 
62.5 mM Tris-HCl, pH 7.6 
12.5 mM MgCl2 
1.25mMATP 
1.25 DTT 
25% (w/v) polyethylene glycol-8000 
1 unit Ligase 
This reaction incubated at room temperature for four and one half hours. The reaction was 
then EtOH precipitated using 5 M ammonium acetate and 95% EtOH. The ligation 
reaction pellet was resuspended in 10 µl ddH20 and used to transfect E. coli. 
4. Transformation of E. coli with C-Nterm/m YEp construct. One µl (20 ng) of 
the precipitated C-Nterm/mYEp ligation reaction was added to 20 µl of ElectroMAX 
DHlOB™ E. coli cells (Life Technologies, Gaithersburg, MD) and the mixture was 
placed in a chilled 1 mm gap disposable micro-electroporation cuvette (BTX, San Diego, 
CA). One µl (0.01 ng) pUC19 DNA (Life Technologies, Gaithersburg, MD) in 20 µl of 
DHlOB™ cells served as a positive control. A 1.7 kV charge was administered using the 
TransPorator™ Plus (BTX, San Diego, CA). The C-Nterm/mYEp transfected E. coli 
from two electroporations were combined in 1 ml of SOC medium. The cells were 
incubated for one hour at 37°C, in a 250 rpm shaker and then distributed equally onto two 
LB/ampicillin agar plates. After a five minutes incubation upright, the plates were inverted 
and incubated at 37°C overnight. The following day, resultant colonies were selected 
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from the plates and amplified in LB/ampicillin liquid media overnight at 37°C in a 250 rpm 
shaking incubator. The same procedure was followed for the cells transfected with the 
positive control pUC19 DNA. 
Cells were harvested from the amplified colonies and plasmid was isolated using 
the QIAprep Spin Plasmid Miniprep Kit. The isolated plasmids were digested with Kpn I 
and Spe I which are 5' and 3' to the multiple cloning site in mYEp, respectively. 
Approximately 100 ng of isolated plasmid (C-Nterm/mYEp) was digested with 10 units of 
Kpn I and 10 units of Spe I in React 4 at 37°C for one hour. DNA loading buffer was 
added to stop the reaction. The digestion reaction was electrophoresed on a 1. 0% 
agaroseffAE gel containing 0.01 µg/ml ethidium bromide at 100 V for one hour and the 
DNA was visualized on an ultraviolet transilluminator. 
Colonies that contained the C-Nterm/mYEp construct were amplified in 
LB/ampicillin liquid media overnight at 37°C, 250 rpm and were then stored as glycerol 
stocks at -70°C. 
Manual DNA SeQJlencin~ 
To confirm the proper reading frame of the C-Nterm/mYEp construct manual 
sequencing was done using the Sequenase™ Version 2.0 DNA Sequencing Kit 
(Amersham, Cleveland, OH). Unless otherwise indicated, all enzymes and buffers used 
for the sequencing reactions were sold with that kit. One µg of C-Nterm/mYEp was 
resuspended in 18 µl ddH20 and 2 µl NaOH, incubated at 37°C for five minutes, then 
EtOH precipitated. Following incubation on dry ice for 10 minutes, the precipitate was 
pelleted by centrifugation (16,000 x g, 20 minutes) and the supernatant was decanted. 
The C-Nterm/mYEp template pellet was washed with 95% EtOH, centrifuged (16,000 x 
g, 10 minutes) and the supernatant discarded. The template was resuspended in 2.0 µl of 
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Sequenase Reaction Buffer and 3.5 pmol of Ya.N-21 primer (Eastman Kodak Company, 
New Haven, CT), heated for two minutes at 65°C in a heat block, then cooled slowly to 
37°C by placing the heat block on the lab bench. 
To the cooled template/primer mixture, the following were added: 1 µl DTT ( 100 
mM); 2.0 µl of 1:10 diluted Labeling Mix (1 µl Labeling Mix in 10 µl ddH20). The 
reaction was started by the addition of 20 µCi [35S] dATP and 2 µl of 1:8 diluted 
Sequenase/buffer solution (1 µl (13 units) Sequenase in 8 µl of Enzyme Dilution Buffer). 
After three and one half minutes at room temperature, a 3 µl aliquot of the reaction mixture 
was added to four tubes each containing 2.5 µl (0.8 µM) of a distinct ddNTP. The tubes 
were incubated for seven minutes at 37°C after which time 4 µl of Stop Solution was 
added. The reactions were stored at-20°C until the following day. 
Premixed 6% polyacrylamide gel casting solution (Life Technologies, 
Gaithersburg, MD) was used to pour the sequencing gel. Eight hundred µl of 10% 
ammonium persulfate was added to the 7 5 ml gel mix solution immediately prior to 
pouring the gel. The sequencing gel polymerized overnight at room temperature. 
The fohowing day, the polymerized gel was mounted on the running apparatus and 
lX Tris-borate/EDTA (TBE) [0.09 M Tris-borate; 0.002 M EDTA (Brown, 1991)] was 
added as a running buffer. The power supply was set at 1220 V, 55 mA, 69 W to warm 
the gel before the samples were loaded. Just before loading, the samples were heated for 
three minutes at 75°C and placed immediately on ice. Three µl from each ddNTP/reaction 
tube was added to a separate well. A long sequencing run (4 hours) was done for optimal 
resolution of larger bands and a short sequencing run (2 hours) was done for optimal 
resolution of smaller bands. The gel was electrophoresed at 1220 V, 55, 71 W. 
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At the end of the run, the gel was removed from the apparatus and fixed in 10% 
methanol (MeOH), 10% glacial acetic acid for one hour at room temperature. The gel was 
then dried for one and one half hours at 80°C and used to expose X-ray film .. The 
autoradiogram was developed and the sequence of C-Nterm/m YEp was read. 
Transformation of S. cerevisiae with C-Nterm/m YEp Construct 
Liquid YPD growth media [l % Bacto-yeast Extract; 2% Bacto-peptone; 2% Bacto 
dextrose (Eastman Kodak Company, 1994)] was inoculated with S. cerevisiae (2095-6 
strain) and incubated at 30°C for 72 hours at 250 rpm. When the OD600 of the culture was 
1.3, cells were harvested by centrifugation (5,000 x g, five minutes, room temperature). 
The supernatant was decanted and cells were resuspended in 10 ml YPD and 200 µl 1 M 
HEPES, pH 8.0. Sterile, cold ddH20 was added to the resuspended cells to increase the 
volume to 25 ml. While swirling gently, 275 µl of 0.9 M cold DTT was added. The cells 
were pelleted by centrifugation (5,000 x g, five minutes, 4°C) and washed sequentially in 
30 ml sterile, cold ddH20; 25 ml sterile, cold ddH20; 2 ml sterile, cold 1 M sorbitol. 
Following the washes, the cells were pelleted by centrifugation (5,000 x g, five minutes, 
4°C) then vigorously resuspended in 50 µl sterile, cold 1 M sorbitol. 
Twenty five ng of the C-Nterm/m YEp construct was added to 40 µl of the washed 
S. cerevisiae cells and the mixture was placed in a sterile, chilled 2 mm gap electroporation 
cuvette. Using the TransPorator™ Plus (BTX, San Diego, CA), the yeast was 
electroporated at 1.5 kV then immediately diluted with 1 ml cold 1 M sorbitol and gently 
resuspended. Five hundred µl of cells were plated onto two synthetic complete medium 
(SCM) minus tryptophan (TRP) plates (Bio 101, La Jolla, CA) and incubated at 30°C for 
48 hours, inverted. Only yeast transfected with the mYEp expression vector can survive 
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on TRP minus media because m YEp encodes a TRP selectable marker. Thus, colonies 
that grew on SCM minus TRP plates should contain mYEP. 
Colonies were selected from the plates and grown in liquid SCM minus TRP for 
72 hours at 30°C, 250 rpm to an OD600 of ~ 8.0. Glycerol stocks [333 µl 60% glycerol; 
667 µl yeast culture] were made and stored at -70°C. An aliquot was also taken to 
inoculate a culture that would be used for protein expression work. 
Inducin~ Protein Expression in S. cerevisiae Transformants 
A 2.5 µl aliquot of the SCM minus TRP culture described above was diluted 1 :20 
in each of three tubes containing 47.5 ml YP4 High Stability Expression Media (YPHSM) 
[1 % dextrose; 3% glycerol; 1 % Bacto-yeast extract; 8% Bacto-peptone; 20 mM CaC12; 
0.05% adenine; 0.05% uracil (Eastman Kodak Company, 1994)] and were incubated at 
30°C for 72 hours at 250 rpm. The cultures were harvested and the cells pelleted by 
centrifugation (16,000 x g, 20 minutes, 4°C). The supematants were saved and later 
evaluated for the presence of secreted recombinant protein. 
Trichloroacetic Acid (fCA) Precipitation and SDS-Polyacrylamide Gel Electrophoresis 
(PAGE) 
To better visualize proteins secreted by yeast, 500 µl of each of the three yeast 
expression culture supematants were concentrated by precipitation with 125 µl 100% 
TCA. After centrifugation (16,000 x g, 20 minutes) the supematants were decanted and 
the pelleted proteins were washed three times in 500 µl ac~tone and again centrifuged 
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(I6,000 x g, five minutes, 4°C). The pellets were resuspended in 50 µl IX sample buffer 
L0.134 M Tris-base, pH 6.8; I% SDS (w/v); 10% glycerol; 0.08% bromophcnol blue 
(w/v) (Harlow and Lane, I988)], 5% ~-mercaptoethanol and size fractionated on a 
denaturing I2% polyacrylamide separating gel, 3.75% polyacrylamide stacking gel using 
electrophoresis buffer [25 mM Tris-base; 200 mM glycine; O. I% SDS (Sambrook et al., 
I989)]. The gel was electrophoresed at I76 V, 36 mA for two hours and stained in 
Coomassie brilliant blue [10% glacial acetic acid; 45% MeOH; O. I% Coomassie brilliant 
blue (w/v)(Sigma Chemical Company, St. Louis, MO)] overnight while shaking. The gel 
was destained [5% MeOH, 7.5% glacial acetic acid] on a shaking plate and protein was 
visualized over a light source. 
Ni2+-NTA Purification of Recombinant C-Nterm Protein 
An Ni2+-NTA affinity column was used to purify recombinant C-Nterm from the 
yeast expression media supernatant. Ni2+-NTA resin (Qiagen Inc., Chatsworth, CA) 
binds the six histidine tagged C-Nterm due to a high affinity interaction between the six 
consecutive histidines and the Ni2+-NTA complex. Find a detailed reference for the 
procedure explained below in The QIAexpressionist, Summer, I992 manual (Qiagen Inc., 
Chatsworth, CA). 
Fifty ml of supernatant from one yeast expression culture was dialyzed against 2 
liters of IX phosphate-buffered saline (PBS) [8.0 g/L NaCl; 0.34 g/L KH2P04; 1.21 g/L 
K2HP04, pH 7.3 (Brown, I99I)] in Spectra/Par 4 dialysis membrane tubing (molecular 
weight cut off: I2-I4,000)(Baxter Diagnostics Inc., McGaw Park, IL) for four hours at 
4°C. The tubing which contained the supernatant was then transferred to 2 liters of fresh 
IX PBS and was incubated at 4°C overnight. The following day, 1.5 ml of the Ni2+-NTA 
resin equilibrated with Column buffer [50 mM Na-P04, pH 8.0; 300 mM NaCl (Qiagen 
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Inc., 1992)] and was added to the dialyzed yeast supernatant. The supernatant/resin slurry 
was incubated on ice and placed on a shaking plate for one hour. The slurry was 
subsequently loaded onto two poly-prep chromatography columns (Bio-Rad LaboraLories, 
Hercules, CA) and the material which did not bind to the columns was collected. (After 
this step, all fractions were collected in 1.0 ml amounts, with the exception of the first 
fraction from each separate wash which was collected in 200-300 µl fractions). The resin 
was washed with 5 ml Wash buffer [50 mM Na-P04; 30 mM NaCl; 10% glycerol, pH 7 .0 
(Qiagen Inc., 1992)] then 5 ml Wash buffer containing 0.5 M imidazole, pH 7.0 was 
applied to elute C-Nterm. Subsequent washes with 5 ml Wash buffer, pH 6.0 and then 5 
ml Wash buffer, pH 4.5 were performed to be sure protein had been eluted from the 
column. Eluants were stored at 4°C. 
To determine which fraction contained the eluted C-Nterm protein, aliquots from 
the eluted fractions were analyzed on denaturing 12% polyacrylamide separating gels, 
3.75% polyacrylamide stacking gels. The gels ran at 176 V, 36 mA, 92 minutes then 120 
V, 92 mA for an additional 28 minutes and proteins were visualized by Coomassie blue 
staining. 
Western Blot Analysis of Ni2+-NTA Purified Protein 
To determine if protein eluted from the Nf+-NTA affinity columns reacted with 
antibodies generated against Pfs230, it was analyzed by western blot. Proteins size 
fractionated by SDS-PAGE were electrophoretically transferred to a nitrocellulose 
membrane for one hour at 100 V using chilled transfer buffer [25 mM Tris-base; 200 mM 
glycine; 20% MeOH (Harlow and Lane, 1988)]. Following the transfer, the nitrocellulose 
filter was blocked in 5% dry milk/lX PBS for 15 minutes at room temperature to prevent 
non-specific antibody binding. The filter was then incubated overnight at 4°C with the 
indicated primary antibodies diluted 1:2000 in lX PBS. The following day, the 
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membranes were washed three times with lX PBS and then incubated for 45 minutes at 
room temperature with the secondary antibodies, Goat-Anti-Mouse IgG alkaline 
phosphatase conjugate (Sigma Chemical Company, St. Louis, MO) diluted 1 :2000 in lX 
PBS. The filter was then washed twice with lX PBS and once with alkaline phosphatase 
buffer [100 mM NaCl; 5 mM MgC12; 100 mM Tris-base, pH 9.5 (Harlow and Lane, 
1988)]. The membrane was subsequently incubated with 16.5 µl 5-bromo-4-chloro-3-
indolylphosphate p-toludine salt (BCIP) (Life Technologies, Gaithersburg, MD), 22 µl 
Nitroblue tetrazolium chloride (NBT) (Life Technologies, Gaithersburg, MD) in 5 ml 
alkaline phosphatase buffer. Bound antibody was visualized by the formation of a blue 
precipitate on the nitrocellulose. 
Glycoprotein Detection Assay 
In contrast to P. falciparum, proteins secreted by yeast are often post-
translationally modified by the addition of large branches of carbohydrates (i.e. mannoses) 
to a secreted protein. This process is known as glycosylation. To determine if 
recombinant C-Nterm was glycosylated, the DIG Glycan Detection Kit (Boehringer 
Mannheim, Indianapolis, IN) was used. Unless otherwise referenced, chemicals used for 
this experiment were supplied with the kit. 
The samples were first electrophoresed on a denaturing 12% polyacrylamide 
separating gel, 3.75% polyacrylamide stacking gel for 20 minutes, 150 V, 36 mA and 
continued for 70 minutes, 174 V, 36 mA. Samples were then electrophoretically 
transferred to nitrocellulose for one hour at 100 V in chilled transfer buffer. Following the 
transfer, the nitrocellulose was washed two times in lX PBS, pH 6.8. To oxidize the 
glycoproteins, the filter was subsequently incubated in sodium metaperiodate for 20 
minutes while shaking at room temperature. After washing the filter three times for 10 
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minutes each in lX PBS, the membrane was incubated in 1 µl DIG-0-3-succinyl-£-
aminocaproic acid hydrazide dissolved in 5 ml sodium acetate buffer, pH 5.5, for one 
hour, shaking at room temperature. Proteins were then stained with ponceau S for five 
minutes (while shaking) to determine if the transfer was successful and to identify the 
major protein bands present. Following this, the nitrocellulose was incubated in Blocking 
Reagent for one hour at room temperature and then the filter was washed three times for 
10 minutes each with lX Tris-buffered saline (TBS) [0.05 M Tris-HCl; 0.15 M NaCl, pH 
7 .5 (Boehringer Mannheim, 1995)] while shaking. The nitrocellulose was then probed 
with 10 µl alkaline phosphatase labeled Anti-digoxigenin antibodies in 10 ml lX TBS 
overnight at 4°C. The following day, the filter was washed three times for 10 minutes 
each with lX TBS. Staining solution [10 ml alkaline phosphatase buffer, pH 9.5; 37.5 µl 
X-phosphate; 50 µl NBT (Boehringer Mannheim, 1995)] made immediately prior to use, 
was added to the filter to visualize reactivity with glycosylated proteins which was 
observed by the presence of bands on the nitrocellulose. 
C-Nterm Protein Sequencin~ 
To directly determine the identity of the highest molecular weight band produced 
by C-Nterm/m YEp transfected yeast, the amino acid sequence of that protein was 
evaluated. Twenty-four ml (-2 µg) of supernatant from yeast transfected with C-
Nterm/m YEp construct was concentrated by adding it to SpectraPor dialysis tubing then 
placing the tubing in one and one half cups of chilled, ground sucrose. As the volume of 
the supernatant progressively decreased, knots were tied to keep the tubing tight around 
the supernatant. After nine hours the volume of the supernatant was approximately 5 ml. 
Three ml of concentrated C-Nterm/mYEp yeast transfected supernatant was sent to Dr. 
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Bassam Wakim, PhD at Loyola University Medical Center in Maywood, IL. Dr. Wakim 
purified the highest molecular weight band of the recombinant protein by High 
Performance Liquid Chromatography (HPLC) using a C4 reversed phase column. A 
fraction of the purified protein was subjected to Staphylococcus aureus (V8) protease 
digestion and peptides were then purified by HPLC using a C4 reversed phase column. 
The amino acid sequence of selected peptides was obtained. 
Yeast Spheroplast Preparation/DNAExtraction 
To determine if the C-Ntenn/mYEp construct had been altered after transfection 
into the yeast, the plasmid was recovered from yeast and transfected into E. coli. The 
plasmid was isolated from the E. coli, purified, and then sent for automated DNA 
sequencing. 
More specifically, to do this, sterile YPD media was inoculated with the C-
Ntenn/m YEp yeast glycerol stock and incubated at 225 rpm, overnight in a 30°C shaking 
incubator. The following day, when the OD600 was 1.3, the culture was centrifuged 
(2,000 x g, 15 minutes, room temperature) and the supernatant was decanted. The cell 
pellet was resuspended in 20 ml of 1 M sorbitol, 20 mM Tris-base, pH 8.0 and then 
centrifuged (2,000 x g, 20 minutes, room temperature). After the supernatant was 
decanted, the cell pellet was resuspended in 2 ml of 20 mM sodium citrate, pH 5.8; 1 M 
sorbitol; 2 mg lyticase (Boehringer Mannheim, Indianapolis, IN) and incubated at 37°C 
for 30 minutes. This mixture was then centrifuged (2040 x g, five minutes, room 
temperature), the supernatant decanted and the cells resuspended in 1 ml of 0.1 M EDTA, 
pH 8.0; 10 mM Tris-base; 1 % sarkosyl; 2 mg proteinase K. The resuspended cells were 
placed at 30°C for 30 minutes then 65°C for 15 minutes. The mixture was brought up to a 
final volume of 10 ml by adding ddH20 and centrifuged (23,420 x g, 25 minutes, 4° C). 
To the resultant supernatant, 1/10 the volume of 5 M ammonium acetate and one volume 
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of isopropanol were added. After the supernatant incubated for 10 minutes at -20°C, the 
mixture was centrifuged (26,890 x g, 15 minutes, 4°C). The supernatant was decanted 
and the resultant pellet was resuspended in 500 µl ddH20. Fifty µg RNase was added to 
the tube and the mixture incubated at 37°C for 30 minutes. To remove proteins, a phenol 
extraction was done by adding 500 µl of Tris-saturated phenol, pH 7 .9 and centrifuging 
the mixture (16,000 x g, 15 minutes, room temperature). The top layer containing the 
DNA was recovered, transferred to a new tube and the above step was repeated twice 
more. To the recovered DNA, 200 µl chloroform was added and the mixture was 
centrifuged at 16,000 x g for 15 minutes. The DNA (top layer) was recovered and 
precipitated overnight at -20°C with one half the volume of 5 M ammonium acetate and 
two times the total volume of 95% EtOH. The following day, the DNA was centrifuged 
(16,000 x g, 20 minutes). The supernatant was decanted and the pellet was resuspended 
in 100 µ195% EtOH, centrifuged (16,000 x g, 10 minutes) and the resultant supernatant 
was decanted. The pellet was resuspended in 20 µl of filter-sterilized TE buffer, pH 8.0. 
Transformation of E. coli with yC-Ntenn/m YEp Construct Recovered from S. cerevisiae 
The DNA obtained from yeast as described above was electroporated into E. coli. 
One µI of DNA was added to 20 µI ElectroMAX E. coli DHlOB™ cells (Life 
Technologies, Gaithersburg, MD) and electroporated at 1.7 kV. This step was repeated 
and both sets of electroporated cells were immediately combined into 1 ml SOC media. 
After incubating the culture at 37°C, 225 rpm for one hour, the cells were distributed onto 
LB/ampicillin agar plates and incubated overnight at 37°C. Only the colonies containing 
the construct recovered from the yeast (yC-Nterm/m YEp) can survive on this medium due 
to the presence of the ampicillin resistance gene in the mYEp vector. The following day, 
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colonies were selected from the plates and grown in LB/ampicillin liquid media overnight 
at 37°C, 250 rpm. 
Plasmid was isolated from the overnight culture by the Qiagen method and was 
evaluated by restriction analysis. Approximately 100 ng of Qiagen purified yC-
Nterm/m YEp was digested with five units of Kpn I and five units of Spe I in lX React 4 
buffer. The reaction was incubated at 37°C for one hour and 6X DNA loading buffer was 
added to stop the reaction. The digestion reaction was electrophoresed on a 1.0% 
agaroseffAE gel, 0.02 µg/ml ethidium bromide at 100 V for 70 minutes. The gel was 
destained in ddH20 at 4°C for three hours and the DNA was visualized on an ultraviolet 
transilluminator. 
Automated DNA Seguencin~ yC-Nterm/mYEp Construct 
To confirm that the construct recovered from the yeast (yC-Nterm/mYEp) was in 
the proper reading frame and to determine if the sequence had been altered by the yeast, 
1.2 µg of the Qiagen purified yC-Nterm/m YEp was sent for automated sequencing at the 
University of Chicago (University of Chicago Sequencing Facility, Chicago, IL). The 
sequence obtained was analyzed using EditView ABI Automated DNA Sequence Viewer, 




To generate S. cerevisiae-produced Pfs230 the first step taken was to produce 
ample quantities of the Yeast N-Terminal Flag Expression Vector (YEp) purchased from 
Eastman Kodak. Towards that end, E. coli strain JM109 was transfected with the YEp 
vector. Because YEp encodes a gene which confers ampicillin resistance, transfected 
bacteria was grown and selected for on LB/ampicillin agar plates. Twenty three colonies 
grew on the plate which contained bacteria transfected with 5 ng of YEp. Twenty colonies 
grew on the plate which contained bacteria transfected with 50 ng of YEp. Of these, six 
colonies were selected (three from each plate) and grown separately in LB/ampicillin liquid 
to generate a clonal population of each colony. Bacteria harvested from the six cultures 
were lysed and the YEp vector was purified and digested with Kpn I. The digests were 
electrophoresed on an agarose/TAE gel to verify that YEp vector was purified (Figure 2). 
Bands from five of the six digests were found to be 7 .37 kB as interpolated by DNA size 
standards. The actual size of YEp is 7.2 kB. No plasmid was recovered from the sixth 
colony. Purified vector obtained from one of the transfected colonies was used for 
subsequent modification. 
The purified YEp was modified to encode a six histidine tag and a Nhe I restriction 
site at the 3' end of the multiple cloning site. The six histidines encoded by the modified 
YEp vector (m YEp) were to be expressed on the carboxy terminus of 
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--9.4kB 
--6.6kB 
Figure 2 . Kpn I digests of YEp vector. Plasmid was Qiagen purified from six colonies of 
JM109 E. coli transfected with the YEp vector. The purified material was digested with 
Kpn I and then size fractionated on a 0.8% agaroseffAE gel. Lanes 1-6 contain Kpn I 
digested material purified from bacterial colonies 1-6, respectively. DNA size standards 
are indicated on the right. 
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C-Nterm protein thus enabling the recombinant protein to be purified using a Ni2+-NTA 
affinity column. Briefly, two synthetic complementary oligonucleotides (sense and 
antisense) which encoded for a six histidine tag and a Nhe I restriction site _were 
phosphorylated and annealed together (Figure 3). The annealed oligonucleotide 
(YEpH6II) was then ligated into the YEp plasmid which had also been previously digested 
with Apa I and Sst II. 
Annealed oligonucleotide YEpH6II 
Alla.I Six His STOP Nhe I Sst II STOP 
ggg/ eeC I GTC I GAC I 6 x CACI TAG I GCT I AGC I CCG I Cgg I taa 
r,.CC/ GOO I CAG I CTG I 6 x GTG I ATC I CGN TCG I GGe I gee I att 
Figure 3. This schematic shows the annealed oligonucleotide which was ligated into the 
YEp vector to encode for six consecutive histidines, a stop codon, and a Nhe I restriction 
site. The oligonucleotides were phosphorylated, annealed together, and ligated into the 
YEp vector via a compatible end ligation into the Apa I and Sst II restriction sites. The 
YEpH611/YEp ligation generated a modified (mYEp) vector which differed from YEp at 
the 3' end of the multiple cloning site. Lower case, bolded and underlined letters represent 
the vector sequence and the upper case letters represent the synthetic oligonucleotide 
sequence. 
E. coli was transfected with the YEpH611/YEp ligation mix and plated out onto 
LB/ampicillin agar plates. Resultant colonies were counted to determine the 
transformation efficiency. This number was compared to the transformation efficiency of 
E. coli that was transfected with the positive control DNA, pUC19 monomer. The 
equation used to determine the transformation efficiency follows: 
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Colony forming units (CFU)/µg = CFU in pUC19 plate* 1x106 pg* dilution factor 
pg pUC19 used µg 
The transformation efficiency calculated for the control, pUC19, plate follows: 
CFU/µg = 150 CFU * 1 x 106 pg * 100 = 1.5 x 109 
10 pg µg 
The transformation efficiency calculated for the m YEp construct follows: 
CFU/µg = 32 CFU * 1 x 106 pg *2 = 2.56 x 104 
2.5 x 103 pg µg 
Six m YEp colonies were selected and grown up overnight in liquid culture. 
Plasmid was isolated and analyzed for the presence of the synthetic oligonucleotide by 
restriction analysis using Nhe I. Because only the plasmid containing YEpH611 (m YEp) 
contains a Nhe I restriction site (and unmodified YEp does not) mYEp plasmids can be 
linearized by a Nhe I digestion while YEp plasmids cannot. Linearized vector would be 
represented by a band migrating at approximately 7.2 kB. Undigested vector (which 
should be seen in the negative control YEp Nhe I digest) would be seen as two bands: one 
just above 7 .2 kB representing relaxed plasmid; one just below 7 .2 kB representing 
supercoiled plasmid. The mYEp and YEp Nhe I digests were electrophoresed on a 0.8% 
agaroseffAE gel containing 0.01 µg/ml ethidium bromide and were visualized using an 
ultraviolet transilluminator. Plasmid from a mYEp colony migrated as one 10.68 kB band 
(as interpolated by size standards using linear regression) following the Nhe I digestion 
suggesting that this plasmid contained the synthetic oligonucleotide (Figure 4). The actual 
size of m YEp is 7.206 kB. The control YEp plasmid Nhe I digest migrated as two bands, 
one interpolated at 11.5 kB and one interpolated at 6.29 kB, consistent with the pattern of 
relaxed and supercoiled plasmid (Figure 4). Both uncut YEp and uncut mYEp which were 
run as controls, also migrated as two bands at 11.5 kB and 6.29 kB. 











Figure 4. Size fractionation of YEp and m YEp Nhe I digests. Reactions were size . 
fractionated on a 0.8% agarose/TAE gel, 0.01 mg/µl ethidium bromide. Undigested YEp 
and m YEp were run as controls. Lane 1 contains 5 µl undigested YEp vector . Lane 2 
contains 5 µl of YEp vector digested with Nhe I. DNA standards are seen in lane 3 and 
the corresponding sizes are indicated on the right. Lane 4 contains 5 µl m YEp vector 
digested with Nhe I. Lane 5 contains 5 µl of undigested m YEp. 
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Pfs230 Expression Vector 
Using mYEp, a Pfs230 expression vector was constructed. To do this, _DNA 
encoding region C-Nterm (base pair #1339 to base pair #1752 of Pfs230) was amplified 
by PCR. Sense and antisense primers which encoded Xho I and Apa I, respectively, at 
the 5' end were used in the reaction. The size of the PCR amplified DNA was evaluated 
via electrophoresis on a 1.2% agaroseffAE gel containing 0.007 µg/ml ethidium bromide 
and was found to be 473 base pairs by interpolation against size standards. This was 
consistent with the predicted 414 base pair size of Pfs230.C-Nterm and thus suggested 
that the appropriate region of Pfs230 had been amplified (Figure 5). 
To facilitate insertion of PCR amplified C-Nterm into the mYEp vector (Figure 6) 
both were digested with Xho I and Apa I generating compatible ends. The double 
digested PCR product and vector were size fractionated on a 1.2% agaroseffAE gel. The 
corresponding bands were isolated and the DNA was recovered from the agarose and 
genecleaned. The 7.2 kB mYEp vector and the 414 base pair PCR amplified C-Nterm 
were ligated together and electroporated into E. coli. The bacteria was plated onto 
LB/ampicillin agar and the transformation efficiency for the C-Nterm/m YEp construct was 
calculated as follows: 
CFU/µg = 200 CFU * 1x106 * 2 = 8.7 x 103 
4.56 x 104 pg µg 
The transformation efficiency for the positive control pUC19 was calculated as follows: 
CFU/µg = 200 CFU * 1 x 106 * 100 = 2 x 109 
10 pg µg 
Three ampicillin resistant colonies were selected, grown up, and the plasmid was isolated. 
Plasmid was digested with Kpn I and Spe I and size fractionated on a 1.0% agaroseffAE 
gel. The cleavage site for Kpn I in mYEp is base pair #1457. The cleavage 
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Figure 5. Size fractionation of PCR amplified Pfs230.C-Nterm. Primers designed to 
flank the sequence of Pfs230.C-Nterm were used to amplify this region via the 
polymerase chain reaction and the products obtained were size fractionated on a 1. 2 % 
agaroseff AE gel. DNA size standards appear in lane 1 and the corresponding sizes are 
indicated on the right. Lanes 2 and 3 each contain 2 µl of the PCR amplified product. 
Alpha 
Pfs230.C-N term 
FLAG Multiple Cloning Site 





Figure 6. Schematic representing the m YEp vector. The position of the restriction sites 
that were used in this project are indicated. The relative location of the six histidine tag, 
the FLAG peptide and stop codons are also indicated. 
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site for Spe I in mYEp is base pair #2031. Thus if a mYEp vector without C-Nterm insert 
was digested with these enzymes, two fragmentc; would result one at 6.626 hase pairs 
representing the vector; one at 57 4 base pairs representing the area of the vector between 
Kpn I and Spe I. If mYEp contained the C-Nterm insert, a digest would result in two 
fragments on an agaroseffAE gel: mYEp at 6.626 kB; C-Nterm at approximately 988 
base pairs (the 414 base pair C-Nterm fragment plus the 574 bases between Kpn I and Spe 
I). Two out of three colonies selected were digested with Kpn I and Spe I. Plasmid from 
one of these colonies is seen in Figure 7 and migrated as two fragments on the 
agaroseffAE gel: one interpolated against size standards to be 7.95 kB; one interpolated 
against size standards to be 931 base pairs (Figure 7). These results suggest that the PCR 
product had been ligated into m YEp. As a control, a sample of the original m YEp which 
had not been ligated with C-Nterm insert, was also digested with Kpn I and Spe I. In 
contrast to the digest of the plasmid purified from C-Nterm/mYEp transfected bacteria, the 
mYEp digest resulted in a band extrapolated against size standards to be 7.95 kB and a 
band extrapolated against size standards to be 555 base pairs. 
Manual DNA Sequencing 
To confirm that the C-Nterm/mYEp construct had been ligated together in the 
proper reading frame, the Qiagen purified C-Nterm/m YEp DNA was manually sequenced. 
Sequencing reactions were performed and then electrophoresed on a 6% polyacrylamide 
gel. An autoradiograph of the sequencing gel was read from base pair #1493 to base pair 
#1507 in the vector and base pair #1 to base pair #263 in C-Nterm (Figure 8). This was 
compared with the reported sequence of C-Nterm/mYEp (Figure 8) to verify the proper 
reading frame. The vector sequence that was read from the autoradiograph was identical 
to the reported sequence of mYEp base pair #1493 to base pair #1507. However, one 







Figure 7. Kpn I and Spe I digests of mYEp and C-Nterm/mYEp. The constructs were 
digested and size fractionated on a 1 % agaroseff AE gel. Lane 1 contains 10 µl of m YEp 
cut with Kpn I and Spe I. Lane 2 contains 10 µl C-Nterm/mYEp cut with Kpn I and Spe 
I. The weights of DNA molecular size standards are indicated on the right. 
Comparison of reported sequence of Pf s230 
and manual seqyencing data 
51 
Reported GAN AANGANAGG/CANGGT/GAN ATA!f AT/CCA!ITT/GGT/GAT 
Manual GANAANGANAGG/CANGGT/GANATA!TAT/CCA!ITT/GGT/GAT 
Reported GANGANGANAANGAT/GANGGTIGGNGANAGTrrITI ACC/TAT 
Manual GANGANGANAANGATIGANGGTIGGNGAN AGTrrIT/ ACC/TAT 
Reported GANAAG/AGC/GAG/GTT/GAT/AANACAfGAT/TGTrrIT/AAA!ITT 
Manual GAN AAG/ AGC/GAG/GTT/GAT/AANACAfGAT/TGTrrIT/AAA!ITT 










Reported TAT/GANACN ACNGANAGT/GGNGATI ACT/GCT/GTA!TCC/GAA 
Reported GAT/TCA!TAT/GAT/AANTAT/GCA!TCT 
Figure 8. The nucleic acid sequence of Pfs230.C-Nterm was determined and compared 
with the reported sequence of Pfs230. The top line represents the nucleic acid sequence of 
Pfs230 and the bottom line represents the data obtained from the manual sequencing of C-
Nterm/m YEp. The underlined nucleotide represents the base not seen on the 
autoradiograph obtained by manual sequencing. 
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reported sequence. Base pair #149 is one of three sequential A's as reported in Pfs230. 
Only two A's were visible on the autoradiograph in that region. There is, however, 
clearly an empty space adjacent to those two A's. 
S. cerevisiae Transformation 
The first step in obtaining S. cerevisiae that expresses C-Nterm was to transfect S. 
cerevisiae with the C-Nterm/mYEp construct S. cerevisiae strain 2095-6 was grown in 
YPD media, harvested, washed, and transfected with the Qiagen purified C-Nterm/m YEp 
construct as described in Materials and Methods. Electroporated yeast was grown on 
SCM minus TRP plates. After three days three colonies were selected and grown in SCM 
minus TRP liquid media. This culture was used to inoculate YPHSM media which 
induces protein expression. Protein expression was evaluated 72 hours post inoculation. 
Yeast expression cultures were fractionated by centrifugation (5,000 x g) and the 
supernatants were harvested. Five hundred µl of supernatant was TCA precipitated and 
resuspended in 50 µI lX sample buffer, 5% ~-mercaptoethanol. Twenty-five µl samples 
of the yeast expression media supernatant were electrophoresed on a 12% polyacrylamide 
separating gel, 3.75% polyacrylamide stacking gel and protein was detected by Coomassie 
blue staining (Figure 9). 
On the Coomassie stained gel seen in Figure 9, there were a number of distinct low 
molecular weight protein bands (seen in lanes 2-4) associated with C-Nterm/mYEp 
transfected yeast supernatant that were not seen in the yeast transfected with YEp alone 
(lane 1). When interpolated by molecular weight standards (Amersham, Cleveland, OH) 
using linear regression, the unique protein bands on this gel appear to be the following 
sizes (major bands are in bold print and underlined): 
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1 2 3 4 
--30kDa 
--21.5 kDa 
Figure 9. TCA precipitated supernatant of yeast transfected with C-Nterm/m YEp. Protein 
expression was evaluated on a 12 % SDS-polyacrylamide gel. Lane 1 contains the 
equivalent of 250 µl YEp transfected yeast supernatant. Lanes 2-4 contain the equivalent 
of 250 µl C-Nterm/m YEp transfected yeast supernatant. Amersham molecular weight size 
standards are indicated on the right. 
Lane 2: 30.58 kDa, 28.48 kDa, 21.04 kDa, 18.58 kDa, 16.11 kDa; 
Lane 3: 30.04 kDa, 27 .98 kDa, 20.31 kDa, 18.25 kDa, 15.83 kDa 
Lane 4: 28.48 kDa. ----
The predicted size of recombinant C-Nterm was 16,270 Da. 
Western Blot Analysis of Proteins in Yeast Supernatant 
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A western blot was performed to determine if the protein bands seen in the 
supernatant of yeast transfected with C-Ntenn/mYEp were recognized by antibodies 
generated to E. coli produced r230.MBP.C (Anti-r230.MBP.C). Anti-r230.MBP.C 
antibodies have been shown to recognize parasite-produced Pfs230 (Williamson et al., 
1995). TCA precipitated supernatant of yeast transfected with YEp alone and yeast 
transfected with C-Ntenn/mYEp were size fractionated on a 15% polyacrylamide 
separating gel, 3.75% polyacrylamide stacking gel. Proteins were electrophoretically 
transferred to two nitrocellulose membranes and the membranes were separately incubated 
with antibodies that were generated against Pfs230 region C (Anti-
r230.MBP .C)(Williamson et al., 1995) and antibodies generated in mice immunized with 
MBP alone (Anti-MBP)(Williamson et al., 1995). The Anti-MBP antibodies were 
included as a control because antibodies to region C were generated in mice vaccinated 
with recombinant Pfs230 produced in E.coli as fusions with MBP. 
Results showed that there were no bands present in the lane corresponding to yeast 
transfected with YEp on the Anti-r230.MBP.C blot. There was reactivity, however, 
between the C-Ntenn/mYEp yeast transfected supernatant and Anti-r230.MBP.C (Data not 
shown). The C-Ntenn/m YEp protein bands on this blot appeared to migrate in the same 
molecular weight range as the C-Ntenn/mYEp transfected yeast supernatant proteins in the 
original Coomassie stained gel (Figure 9). No reactivity was seen with YEp transfected 
yeast supernatant or C-Ntenn/mYEp transfected yeast supernatant on the Anti-MBP blot 
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(Data not shown). This suggested that there was no irnmuno-crossreactivity between 
Anti-MBP and the proteins produced in YEp transfected yeast or C-Nterm/mYEp 
transf ected yeast. 
Ni2+ -NT A Purification of Recombinant C-Nterm Protein 
A Ni2+-NTA affinity column, which selectively binds six histidine tagged proteins, 
was used to purify recombinant C-Nterm from the C-Nterm/m YEp transfected S . 
cerevisiae culture supernatant. C-Nterm/mYEp transfected yeast supernatant was dialyzed 
against IX PBS. Ni2+-NTA resin equilibrated with Column buffer was added to the 
dialyzed yeast supernatant and the mixture incubated for one hour on ice. The 
supernatant/resin slurry was loaded onto two columns to increase the flow rate through the 
columns. Fractions eluted from the columns were then evaluated for protein by SDS-
p AGE and western blot analyses. 
Aliquots taken throughout the purification were size fractionated on a SDS-PAGE 
gel (Figure 10). Protein bands were interpolated against Sigma molecular weight 
standards (Sigma Chemical Company, St. Louis, MO). Both high and low molecular 
weight bands were present in the IX PBS-dialyzed C-Nterm/m YEp transfected yeast 
supernatant and in the material which was applied to but did not bind to the Ni2+ -NT A 
affinity column (lanes I and 2, respectively). The bands in lanes I and 2 were found to 
migrateinanearlyidenticalpatternfrom 75.I5 kDa-I8.20 kDa except for the band in the 
25 kDa range which was fainter in lane 2. Lanes 3-5 which contained fractions from the 
pH 7.0 wash contained no bands. Only one eluant (lane 8) from the pH 7.0 Wash 
Buffer/irnidazole wash contained protein (Figure 10). The bands in lane 8 were 
interpolated against Sigma molecular weight standards by linear regression and were 





:+---- 24 kDa 
-- 18.4kDa 
Figure 10. Nf+-NTA purification of protein from C-Nterm/mYEp transfected yeast. 
Material eluted from the affinity column was size fractionated on a 12% SDS-
polyacrylamide gel and stained in Coomassie blue. Lane 1 contains a 20 µl sample of lX 
PBS-dialyzed C-Nterm/mYEp transfected yeast supernatant prior to adding the Ni2+-NTA · 
resin. Lane 2 contains 20 µl of material which was applied to but did not bind to the Nf+ -
NTA affinity column. Lanes 3-5 contain 20 µl of material recovered after the first three 
sequential pH 7.0 washes. Lane 6 contains 10 µl Sigma molecular weight standards and 
the corresponding sizes are indicated on the right. Lanes 7-10 contain 20 µl fractions of 
material eluted from the column after applying pH 7.0 Wash buffer/0.5 M imidazole. 
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bands seen in lane 8 were similar in size to the low molecular weight bands seen in the 
original C-Nterm/m YEp transfected yeast dialysate (lane 1) and in the material which did 
not bind to the affinity column (lane 2). However the higher molecular weight bands. seen 
in the dialyzed, unpurified yeast supernatant (lane 1) and in the material which flowed 
through the affinity column (lane 2) were not present in lane 8. An elution pattern similar 
to the one in Figure 10 was seen on the gel in which protein eluted from the second Ni2+ 
affinity column was electrophoresed (Data not shown). 
Characterization of Purified C-Nterm 
1. Western Blot Analyses of Ni2+-NTA Purified Protein. Using antibodies with 
different specificities, the Ni2+ -NT A purified protein was characterized by western blot 
analyses. To determine the immuno-crossreactivity with Pfs230 region C produced in E. 
coli, protein eluted from the column was probed with Anti-r230.MBP.C. Additionally, 
monoclonal antibodies against the FLAG polypeptide (Anti-FLAG Ml) (Eastman Kodak 
Company, New Haven, CT) were used to determine if the amino terminus of C-Nterm 
was present. The DNA sequence which encodes the FLAG peptide is located at the 5' end 
of the MCS in m YEp but is downstream of the a signal secretory sequence. As the 
protein moves through the secretory pathway, the a signal sequence is removed, leaving 
the FLAG peptide at the amino terminus of C-Nterm. Anti-FLAG Ml only reacts with the 
FLAG peptide when it is on the exposed amino terminus of a recombinant protein. 
Lastly, protein purified from the Ni2+ column was also probed with antibodies to MBP 
(Anti-MBP) to be sure that reactivity with Anti-r230.MBP.C was specific for r230.C and 
not its fusion partner, MBP. Reactivity of purified C-Nterm with Anti-MBP would call 
into question any reactivity seen with Anti-r230.MBP.C. 
58 
As a negative control, the protein pattern and immunoreactivity of supernatant from 
yeast transfected with YEp alone was compared with the immunoreactivity of selected 
fractions of supernatant from yeast transfected with C-Nterm/mYEp. A Coomassie 
stained gel of this material (Figure 11.A) revealed a number of higher molecular weight 
proteins in the YEp transfected yeast that were not visible in the yeast supernatant 
transfected with the C-Nterm/mYEp construct. The equivalent of 250 µl TCA precipitated 
yeast transfected with YEp alone was loaded in lane 1. Bands were interpolated against 
Sigma molecular weight standards by linear regression and were found to migrate between 
75.58 kDa and 49.66 kDa. This correlates very well with the pattern of YEp transfected 
yeast proteins also seen in Figure 10. There were also less intense bands present in the 
41.62 kDa to 24.48 kDa range. In lane 2, only 20 µl of lX PBS-dialyzed supernatant 
from yeast transfected with C-Nterm/mYEp was loaded. Lane 3 contained 20 µl of C-
Nterm/m YEp transfected yeast supernatant which was applied to but did not bind to the 
affinity column. Lane 4 contained 5 µl of material eluted from the affinity column after 
applying imidazole. The amount of protein seen in lane 2, which represents material 
which did not bind to the affinity column, was significantly lower than the amount of 
protein in lane 4 (Figure 11.A). 
Only lanes 2-4 which correspond to C-Nterm/mYEp transfected yeast showed 
reactivity with Anti-r230.MBP.C (Figure 11.B). No bands were seen in the negative 
control lane (lane 1) which corresponds to the equivalent of 250 µl TCA precipitated yeast 
transfected with YEp alone. Reactivity was seen in lane 2 where 20 µl of lX PBS-
dialyzed supernatant from yeast transfected with C-Nterm/mYEp was loaded. Reactivity 
was also seen in lane 3 which contained 20 µl of C-Nterm/mYEp transfected yeast 
supernatant that was applied to but did not bind to the affinity column. Additionally, 
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reactivity was observed in lane 4 which contained 5 µl of material eluted from the affinity 
column. The protein bands seen in lanes 2-4 migrated in a nearly identical fashion to the 
bands in the Coomassie stained gel, Figure 11.A. These data suggested that Anti-
r230.MBP .C was specific for protein that was only present in yeast transfected with the 
C-Nterm/mYEp and that the reacting protein was probably Pfs230.C-Nterm. It also 
suggested that there was no crossreactivity between the Anti-r230.MBP.C antibodies and 
secreted yeast proteins. 
Similar to the previous blot, only lanes 2-4 which correspond to C-Nterm/mYEp 
transfected yeast showed reactivity with Anti-FLAG Ml (Figure 11.C). The 
immunostaining pattern was nearly identical to the pattern seen in the Anti-r230.MBP.C 
blot (Figure 11.B) and Coomassie stained gel (Figure 11.A) . No bands were seen in the 
negative control lane (lane 1) which corresponds to the equivalent of 250 µl TCA 
precipitated supernatant from yeast transfected with YEp alone. Because Anti-FLAG Ml 
only reacts with the FLAG peptide when it is exposed at the amino terminus of a protein, 
this suggested that the FLAG peptide was present on the amino terminus of recombinant 
Pfs230.C-Nterm. Additionally, all of the bands that reacted with Anti-r230.MBP.C 
reacted with Anti-FLAG Ml (Figures 11.B and 11.C). The protein bands in the 
Coomassie stained gel as well as the two immunoblots seen in Figure 11.A,B,C were 
found to migrate (by extrapolation using linear regression) between 30.83 kDa to 16.09 
kDa. 
To assay reactivity of purified C-Nterm with Anti-MBP, protein eluted from the 
Ni2+ affinity column was electrophoresed on a 15% polyacrylamide separating gel, 3.75% 
polyacrylamide stacking gel. A 15% gel was used in order to better visualize the lower 
molecular weight bands associated with C-Nterm and determine how they correlate with 
bands on a 12% denaturing gel. Part of a 15% gel was Coomassie stained while the other 
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Panel A Panel B Panel C 
Fi&ure 11.A.B.C. Coomassie stammg and immunoblot analyses of purified and 
unpurified proteins. On a 12% SDS-polyacrylamide gel, samples of YEp transfected yeast 
supernatant as well as unpurified and purified samples from C-Nterm/m YEp transfected 
yeast supernatant were electrophoresed. Proteins in panel A were stained by Coomassie 
blue. Proteins in panel B were electrophoretically transferred to nitrocellulose and probed 
with Anti-r230.MBP.C. Proteins in panel C were electrophoretically transferred to 
nitrocellulose and probed with Anti-FLAG Ml. Lane 1 in all three panels contained the 
equivalent of 250 µl YEp transfected yeast supernatant. Lane 2 in all three panels 
contained 20 µl of IX PBS dialyzed C-Nterm/mYEp transfected yeast supernatant before 
it was purified. Lane 3 in all three panels contained 20 µl material which was applied to 
but did not bind to the affinity column. Lane 4 in all three panels contains 5 µl of protein 
eluted from the Ni2+-NTA affinity column. Molecular weight standards are seen on the left 
in panels B and C and the corresponding sizes for all panels are indicated on the far iight. 
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part was electrophoretically transferred to nitrocellulose and probed with Anti-MBP. The 
Coomassie stained gel showed several bands associated with the C-Nterm eluant and those 
bands were interpolated against Amersham molecular weight standards as well as Sigma 
molecular weight standards (Figure 12). In contrast to the Sigma standards, Amersham 
standards are pre-stained and are therefore a less accurate reflection of size than are the 
Sigma standards. The covalent attachment of dyes to the proteins causes the Amersham 
standards to migrate more slowly than their true molecular weight (Amersham 
Corporation, 1996). As seen in Figure 12, the sizes of C-Nterm bands interpolated by 
Amersham standards and Sigma standards using linear regression ranged as follows: 
Amersham standards Sigma standards 
28.46kDa 26.22kDa 
26.94kDa 25.06kDa 
24.13 kDa 22.88 kDa 
21.62 kDa 20.90kDa 





No reactivity was seen with C-Nterm on the Anti-MBP western blot (Data not shown) 
suggesting that Anti-r230.MBP.C is truly recognizing C-Nterm and not MBP. 
2. Glycoprotein Detection. Because Pfs230.C-Nterm appeared to be a higher molecular 
weight than the calculated 16,270 kDa, it was necessary to consider if the protein had been 
posttranslationally modified. A common posttranslational modification of proteins 
expressed and secreted by yeast is glycosylation. To test for the presence of 










14.3 kDa 14.3 kDa 
Fi&ure 12. Electrophoretic analysis of purified C-Nterm on a 15% SDS-polyacrylamide 
gel. Purified C-Nterm was size fractionated on a 15% SDS-polyacrylamide gel and its 
size interpolated against Amersham and Sigma molecular weight markers. Lane 1 contains 
Amersham molecular weight standards and the sizes are indicated on the left. Lane 2 
contains 3 µl of Ni2+ purified C-Nterm. Lane 3 contains Sigma molecular weight 
standards and the corresponding sizes are indicated on the right. 
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nitrocellulose. For comparison, IX PBS-dialyzed yeast supernatant from yeast 
transfected with C-Nterrn/m YEp was loaded in lane 1 while an aliquot of material which 
did not bind to the Ni2+-NTA affinity column was loaded in lane 3. Glycoproteins _were 
detected using the Glycan Detection Kit (Boehringer Mannheim, Indianapolis, IN) 
described in the Materials and Methods. As seen in Figure 13 there are several high 
molecular weight bands which showed a very similar pattern of reactivity in both lanes. 
The bands in lane 1 were interpolated against Amersham molecular weight standards by 
linear regression and were found to migrate between 97.51 kDa and 41.35 kDa (Figure 
13). The bands in lane 3 migrated between 97.51 kDa and 42.73 kDa (Figure 13). No 
bands in the 28 kDa-16 kDa range (apparent weight of C-Nterm as interpolated by 
Amersham standards) showed reactivity (Figure 13). 
C-Nterm Protein Sequencinf: 
Because the eluted protein was estimated to be 10 kDa larger than the theoretical 
weight, the possibility that the amino acid sequence of the protein had been altered, 
perhaps by a mutation or rearrangement in the DNA, was considered. The major (highest 
molecular weight) C-Nterm band was purified using HPLC and was then subjected to 
Staphylococcus aureus (V8) protease digestion. Peptides were purified by HPLC using a 
C4 reversed phase column (Dr. Bassam Wakim, PhD). A peptide 10 amino acids in 
length and a peptide 17 amino acids in length were sequenced (Figure 14) and found to be 
identical with the reported sequence of Pfs230.C-Nterm (amino acid 8 to amino acid 17 
and amino acid 42 to amino acid 58, respectively)(Figure 14). 
C-Nterm DNA Sequencinf: 
Although the amino acid sequence of the peptides obtained from C-Nterm were 
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Figure 13 . Glycoprotein analysis of C-Nterm/mYEp transfected yeast supernatant. 
Proteins were size fractionated on a 12% SDS-polyacrylamide gel, electrophoretically 
transferred to a nitrocellulose membrane, and assayed for the presence of carbohydrate 
moieties. Lane 1 contains 20 µl of IX PBS dialyzed C-Nterm/mYEp transfected yeast 
supernatant. Lane 2 contains Amersham molecular weight standards and corresponding 
sizes are indicated on the right. Lane 3 contains 20 µl of C-Nterm/m YEp transfected yeast 
material that was applied but did not bind to the Ni2+-NTA affinity column. 
Amino acid sequence of 
Pfs230.C-Nterm 
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Reported E K E R Q G E I Y P F G D E E E K D E G G E S F T Y E K S E V 
Reported DK TDLFKFIEG G EG DDVYK VDG SK VIL DD D TIS 
Reported RV S K K HT ARD GEY G EA V ED GEN V I K I I R S V L Q S 
Reported GALP S VG VD ELD KID L S YETT E S G D TA V S ED S Y D 
Reported KY A S 
Fi~ure 14. Peptide sequencing data of yeast expressed Pfs230.C-Nterm. This schematic 
illustrates the reported amino acid sequence of Pfs230.C-Nterm and the two peptides 
obtained from protein sequencing are underlined. The bolded, lower case amino acid 
(#57) obtained in the peptide sequence represents the questionable region of substitution in 
yC-Nterm/mYEp DNA sequencing data (see Figure 16). 
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correct, there was still the possibility that the DNA sequence of C-Nterm had been altered 
downstream of amino acid 58 and had disrupted the stop codons, resulting in a larger 
protein. This could have been caused by a mutation in the stop codons themselves. or a 
change in the reading frame upstream from the stop codons. To determine if yeast had 
rearranged the plasmid, the C-Nterm/mYEp construct was recovered. The first step in 
harvesting the construct from yeast involved spheroplasting the yeast using lyticase. Two 
tests were used to determine if the spheroplasting was successful: 1) precipitate formation 
in 1Msorbitol2) lysis in 2% SDS. These experiments suggested that the yeast cell wall 
had been removed making the yeast sensitive to detergent lysis. Proteinase K was then 
added to the spheroplasts and a phenol extraction was performed to remove protein. The 
DNA was further purified by a chloroform extraction and was used to transfect E. coli. 
To select for ampicillin resistance, transfected bacteria was plated onto LB/agar plates 
containing ampicillin. Only colonies which contained m YEp vector should be resistant to 
ampicillin and therefore able to survive. Both the pUC19 control plate and the 
experimental plates were confluent therefore transformation efficiency was not determined. 
Plasmid purified from amplified yC-Nterm/mYEp colonies was compared with the 
original construct C-Nterm/mYEp (construct before it was transfected into yeast) by 
restriction analysis using Kpn I and Spe I. A Kpn I site is 44 base pairs upstream of the 
C-Nterm inse11 in the mYEp vector. A Spe I site is 494 base pairs downstream of the C-
Nterm insert. A digest with Kpn I and Spe I of both C-Nterm/mYEp and yC-
Nterm/mYEp resulted in two fragments on a 1.0% agaroseffAE gel (Figure 15). The 
sizes of these bands were interpolated against size standards by linear regression. The 
bands for yC-Nterm/mYEp were found to migrate at: a band at 7.95 kB base pairs 
(mYEp); a second band at 813 base pairs (the approximate size of the insert (414 base 
pairs) plus the additional mYEp vector sequence (574 base pairs)). The sizes of the C-
Nterm/m YEp bands interpolated as follows: a band at 8.10 kB and a band at 813 base 
pairs. Thus the size of the m YEp and C-Nterm fragments were the same both before and 








Figure 15. Restriction digests of yC-Nterm/mYEp and C-Nterm/mYEp. To compare to 
size of the inserts, yC-Nterm/mYEp and C-Nterm/mYEp were digested with Kpn I and 
Spe I (enzymes flanking the C-Nterm insert). These digests were size fractionated on a 
1 % agaroseffAE gel. Lane 1 contains DNA size standards with the corresponding sizes 
indicated on the right. Lane 2 contains 25 µl of the yC-Nterm/m YEp digest. Lane 3 
contains 10 µl of the C-Nterm/mYEp digest. 
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after transfection into yeast. This suggests that the yeast made no major rearrangements 
that altered the size of the plasmid. 
Automated DNA Sequencini: 
The results of the restriction endonuclease digestion of yC-Nterm/m YEp showed a 
pattern of bands consistent with the size of the vector (7 .2 kB) and the size of the insert 
(414 base pairs). However, the reading frame of yC-Nterm/mYEp DNA still could have 
altered by a single base deletion or insertion that would not cause a dramatic change in the 
size of the mYEp and C-Nterm fragments on an agaroseffAE gel. Thus, to further 
determine if the yC-Nterm/mYEp construct had been altered by the yeast, 0.3 µg/µl of 
Qiagen purified yC-Nterm/mYEp was sent to the University of Chicago, Chicago, IL for 
automated sequencing. The construct was sequenced from both the 5' end and the 3' end 
using 0.8 pmol/µl of the YaN-21 sense primer and YcC-21 antisense primer, respectively 
(Eastman Kodak Company, New Haven, CT). These primers correspond to sequence in 
mYEp. The resulting chromatogram was read (Figure 16) and compared with the known 
sequence Pfs230.C-Nterm (Figure 16). 
The chromatogram generated using primer YaN-21 (corresponding to vector base 
pairs #1388-#1408) was read beginning at vector base pair #1412, which is in the FLAG 
sequence of mYEp (Figure 16). The chromatogram was read up to and including vector 
base pair #1567, which is 3' to the six histidine tag and the two stop codons in the mYEp 
vector. Pfs230.C-Nterm was inserted into the vector in between base pair #1502 and base 
pair #1537. 
The chromatogram generated using primer YcC-21 (corresponding to vector base 
pairs #1633-#1613) was read beginning at vector base pair #1582, which is in the CYCl 









Manual GAAi AAA/GAAi AGG/CAA/GGT/GAA/ AT A/TAT 
Protein E K E R Q G E ~ 
Reported CCA/TTT/GGT/GAT/GAA/GAA/GAA/ AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT 
Automated CCA/TTT/GGT/GAT/GAA/GAA/GAA/AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT 
Manual CCA/TTT/GGT/GAT/GAA/GAA/GAA/AAA/GAT/GAA/GGT/GGA/GAA/AGT/TTT 




Protein T Y E K S E V D K T D L F K F 
Reported AT A/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GT A/TAT/ AAA/GTG/GAT/GGT/TCC 
Automated AT A/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GT A/TAT/ AAA/GTG/GAT/GGT/TCC 
Manual AT A/GAA/GGG/GGT/GAA/GGA/GAT/GAT/GT A/TAT/ A_A/GTG/GAT/GGT/TCC 








Protein H T A R D G E Y G E Y G E A V 
Figure 16. DNA sequence of yC-Nterm/mYEp. The top line of the schematic represents 
the reported sequence of Pfs230 and m YEp. The second line reports the data obtained 
from automated sequencing of yC-Nterm/mYEp. The third line shows the sequence read 
from the autoradiograph of manually sequenced C-Nterm/mYEp. Vector sequence is in 
lower case letters and Pfs230 sequence in upper case. Underlined, bolded nucleotides 
indicate discrepancies between that sequence and the reported sequence of Pfs230. Stop 



























EDGE NV I KI IRS V L Q 
AGT/GGT/GCNTINCCNAGT/GTNGGT/GTI/GAT/GAG/TTNGAT/AANATC 
AGT/GGTIGCNTTNCCNAGTIGTNGGT/GTI/GAT/GGGITINGAT/AANATC 
S G A L P S V GVD ELD KI 
GATITIGITCA/TAT/GANACNACNGANAGT/GGNGATIACT/GCTIGTAITCC 
GATITIGITCA/TAT/GANACNACNGANAGT/GGNGAT/ACT/GCT/GTA/TCC 
D L S Y E T TES GD T AV S 
6 his tag 
GANGAT/TCA/TAT/GAT/AANTAT/GCA/TCT/ggg/ccc/gtc/gac/cac/cac/cac/cac/cac 
GANG~T/TCA/TAT/GAT/AANTAT/GCA/TCT/ggg/ccc/gtc/gac/cac/cac/cac/cac/cac 




Fi~ure 16 (continued from pa~e 69). DNA sequence of yC-Nterm/mYEp. The top line of 
the schematic represents the reported sequence of Pfs230 and mYEp. The second line 
reports the data obtained from automated sequencing of yC-Ntenn/mYEp. The third line 
shows the sequence read from the autoradiograph of manually sequenced C-Ntenn/mYEp. 
Vector sequence is in lower case letters and Pfs230 sequence in upper case. Underlined, 
bolded nucleotides indicate discrepancies between that sequence and the reported sequence 
of Pfs230. Stop codons in the vector as well as the six histidine tag are noted. 
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vector base pair #1343, which is in the a signal secretory sequence of the mYEp vector 
(Figure 16). 
Thus the entire Pfs230.C-Nterm insert sequence and several base pairs before and 
after were sequenced in both directions. Three discrepancies were found between the 
chromatogram for these runs and the reported sequence of the Pfs230. The first 
discrepancy was noted at insert base pair #170, where there was a C instead of the 
predicted base pair, T (Figure 16). In contrast, data for the protein sequence of C-Nterm, 
corresponding to base pair #170 of C-Nterm, read as predicted by the reported sequence 
of Pfs230 (Figure 16). The second discrepancy was found at insert base pair #329, where 
there was a G instead of the predicted base pair, A (Figure 16). Lastly, insert base pair 
#392 should have been an A instead of the G seen in the chromatogram (Figure 16). Base 
pair #392 was actually part of the synthetic primer used in the PCR. 
To summarize, the sequencing runs using the YaN-21 and the YcC-21 primers 
overlapped for much of the mYEp vector and for all of the C-Nterm insert. Sequencing 
from both directions indicated differences between the automated sequence and the 
reported sequence of Pfs230 in the same three base pairs. No deletions or insertions were 
identified in the stop codons suggesting that the reading frame had not been altered. 
CHAPTER IV 
DISCUSSION 
In previous studies Pfs230 was expressed as six separate MBP fusion proteins in 
E. coli (Williamson et al., 1995). Results from mice vaccinations with one of those six 
recombinants, r230/MBP.C, suggested this region may be a possible transmission-
blocking vaccine candidate. In mosquitoes fed on antisera generated to r230/MBP.C 
parasite infectivity was reduced 71.2-89.8% (Williamson et al., 1995). While 71.2-
89.8% reduction in parasite infectivity is impressive, an effective transmission-blocking 
vaccine must reduce infectivity completely. One possible explanation why r230/MBP.C 
failed to reduce parasite infectivity in the mosquito midgut entirely may be that the 
recombinant protein did not fold properly in the E. coli cytosol, a reduced environment. 
Previous studies have determined that Pfs230-specific monoclonal antibodies require 
proper protein conformation in order to rec·ognize antigens and that these monoclonal 
antibodies are reduction sensitive (Read et al., 1994). 
Possibly the most important aspect in developing a vaccine is that a synthetic 
antigen accurately mimics the native antigen structure. A previous study with P. 
falciparum protein Ff s25 showed that a yeast expression system produced a potent antigen 
which induced transmission-blocking while E.coli did not (Kaslow and Shiloach, 1994). 
Being a eukaryote, proteins expressed in yeast can be targeted to an extensive secretory 
pathway which allows the protein to be generated in a non-reduced environment. A 
crucial element in this secretory pathway is the rough endoplasmic reticulum (absent in E. 
coli) which contains proteins specifically involved in the regulation of folding (i.e. 
chaperones, isomerases). Therefore synthesis of recombinant polypeptides via a yeast 
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expression system may generate a more accurate representation of parasite-produced 
Pfs230 than an E. coli expression system. 
The objective of this study was to produce a small part of Pfs230 region C, C-
Nterm (amino acid 447 to amino acid 584), using a yeast expression system. Yeast N-
terminal Flag Expression System (YEp) was chosen as the vector. YEp encodes a two 
micron circle and a tryptophan selectable marker for growth and selection in yeast. Protein 
expression in yeast transf ected with the YEp vector is regulated by the alcohol 
dehydrogenase promoter (ADH2). ADH2 is a strong yeast promoter capable of directing 
extremely high intracellular levels of (foreign) protein expression. This could be a 
problem if the recombinant, foreign protein is toxic to the yeast (fuite and Oliver, 1991). 
To alleviate this, the ADH2 promoter is repressed in the presence of glucose while initial 
yeast cell growth occurs. Once the yeast have metabolized the glucose the ADH2 promoter 
is derepressed to a high level and protein expression begins. YEp vector also encodes an 
a leader sequence which targets the ribosome to the rough endoplasmic reticulum 
membrane. After translocation across the rough endoplasmic reticulum, the signal 
sequence is cleaved by a membrane bound protease. This cleavage leaves the 
immunogenic FLAG peptide on the exposed amino terminus of the recombinant protein. 
YEp was modified to m YEp by adding a Nhe I restriction site and six histidines at 
the 3' end of the MCS using a synthetic oligonucleotide. The addition of the six histidines 
to the carboxy terminus of recombinant yeast-expressed C-Nterm protein provided the 
option of purifying the recombinant protein with a Nf+-NTA column. Proteins with six 
histidines at either the amino or carboxy terminus bind to a Nf+-NTA affinity column with 
a greater affinity than most antibodies and antigens (Qiagen Inc., 1992). The FLAG 
peptide at the amino terminus of C-Nterm could also be used to purify the recombinant 
using a Anti-FLAG Ml affinity column. Together the FLAG and six histidines could be 
used as indicators to determine if full length protein was present. The modified vector 
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(mYEp) is 7.2 kB and was distinguished on an agaroseffAE gel from unmodified YEp by 
a restriction endonuclease digestion with Nhe I, a site unique to m YEp. 
Using the modified vector, the C-Nterm/mYEp construct was developed. . C-
Nterm was PCR amplified using oligonucleotide primers corresponding to base pair 
#1339 to base pair #1752 (encoding amino acid 447 to amino acid 584) in Pfs230. C-
Nterm was then digested with Xho I and Apa I restriction enzymes and ligated into the 
corresponding sites in m YEp. Transformation efficiency was calculated as a measure of 
quality control for future ligations. The 1.5 x 109 CFU transformation efficiency of 
pUC19 indicated that the technique was performed correctly. The efficiency for the C-
Nterm/m YEp ligation mix (2.56 x 104 CFU) was low compared to the controls but this 
was expected since the control plasmid was supercoiled. The presence of the C-Nterm 
insert in m YEp was confirmed by restriction analysis using Kpn I and Spe I. Results 
showed two bands on an agaroseffAE gel which were by molecular size standards using 
linear regression and found to be 7 .95 kB and 931 base pairs. These are the approximate 
sizes of mYEp and C-Nterm plus vector sequence, respectively, and thus the presence of 
these bands indicated that the construct had been produced. 
Manual sequencing confirmed that C-Nterm/mYEp was produced and more 
importantly that C-Nterm/mYEp was in the proper reading frame. Sequence was obtained 
starting with 15 base pairs of the vector (corresponding to vector base pair #1493 to base 
pair #1507). These base pairs were read and found to correlate with the actual sequence of 
m YEp (Figure 7). The vector sequence ended at the Xho I restriction site (base pair # 1502 
to base pair #1507) and the sequence corresponding to Pfs230 started. This indicated that 
C-Nterm was ligated into mYEp at the intended site and that the reading frame was 
maintained. For Pfs230.C-Nterm, base pair #1 to base pair #263 of the 404 base pair 
C-Nterm were readable on the autoradiograph. Within that sequence only one mismatch 
with the predicted sequence of Pfs230 was found. Base pair #149, which should have 
been nucleotide A, was not seen on the autoradiograph. All other nucleotides read from 
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the autoradiograph conformed to the reported sequence of Pfs230.C-Nterm. Base pairs 
#148 and #150 (like base pair #149) are also A's and there is a visible gap between them 
on the autoradiograph indicating that a base was probably present but no ddATP_ was 
incorporated. If, however, this base pair was missing, the reading frame of C-
Nterm/mYEp downstream to base pair #149 would have been altered. This seems 
unlikely because base pair #149 was identified later in automated sequencing of yC-
Nterm/mYEp, to which C-Nterm/mYEp was a predecessor. Additionally, amino acid 50 
which is encoded by base pairs #148-#150 was a lysine on the peptide sequencing data. 
This conforms with the reported sequence of Pfs230. Furthermore, a pattern on the 
autoradiograph near the 3' end of the template appeared to be several consecutive GTC 
codons. The GTC codon encodes the amino acid histidine. This region probably 
corresponds to the six histidine tag encoded at the 3' end of the multiple cloning site in 
mYEp and suggested that the full length C-Nterm/mYEp DNA was present. 
Since the restriction digest and sequencing results confirmed that the construct had 
been produced, the next stage of the project involved transfecting yeast with C-
Nterm/m YEp. Yeast was transfected with C-Nterm/mYEp, grown on SCM minus 
tryptophan/agar plates, resultant colonies were selected and then amplified further in SCM 
minus tryptophan liquid culture. Protein expression was induced in YPHSM expression 
media which contained a fixed amount of glucose, the preferential energy source of yeast. 
Once glucose is depleted by yeast metabolism (-24 hours) the yeast alcohol 
dehydrogenase promoter (ADH2) is derepressed and protein expression begins. TCA-
precipitated aliquots of C-Nterm/m YEp transfected yeast supernatant were loaded on a 
SDS-polyacrylamide gel to evaluate protein expression. As reported in the results and as 
seen in Figure 9, there were several bands between 30 kDa-16 kDa (with a major band at 
28 kDa +/- 0.5 kDa) when interpolated by Amersham standards. These bands were 
present in the lanes (2-4) which contained C-Nterm/mYEp transfected yeast supernatant 
and were absent in the yeast transfected with YEp vector alone (lane 1). This suggests that 
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these unique bands correspond to C-Nterm. Many higher molecular weight proteins were 
present in all four lanes (including lane 1 ), but these were not as visible as the lower 
molecular weight bands and did not reproduce well in the photograph. The theoretical size 
of C-Nterm is 16,270 Da. 
Samples of yeast supernatant transfected with YEp alone and yeast transfected with 
C-Nterm/mYEp were electrophoretically blotted onto nitrocellulose and probed with Anti-
r230.MBP.C antibodies and Anti-MBP antibodies. In the Anti-r230.MBP.C immunoblot, 
no reactivity was seen in the lane which contained YEp transfected yeast supernatant. 
Several bands were present, however, in the lane which contained C-Nterm/mYEp 
transfected yeast supernatant and were interpolated to migrate at 26.39 kDa, 23.31 kDa 
and 19.35 kDa. These values are bracketed by the same molecular weight range seen in 
the original Coomassie gel on which C-Nterm/mYEp transfected supernatant was 
electrophoresed (Figure 9). The reactivity of bands unique to C-Nterm/mYEp transfected 
yeast supernatant with Anti-r230.MBP.C antibodies strengthened the suggestion that C-
Nterm was being expressed. 
As a control, YEp transfected yeast supernatant and C-Nterm/mYEp transfected 
yeast supernatant were probed with Anti-MBP antibodies and no reactivity was seen. 
Taken together, the Anti-r230.MBP.C and Anti-MBP immunoblots indicated that the 
reactivity of Anti-r230.MBP.C with C-Nterm/mYEp transfected yeast proteins was not 
due to immuno-crossreactivity of the proteins with antibodies to MBP. This strongly 
suggests that the protein recognized by Anti-r230.MBP.C has amino acid homology to 
Pfs230.C, as would C-Nterm. 
Ni2+ -NT A purification was used to isolate full length C-Nterm from the transfected 
yeast supernatant. As mentioned previously, the Ni2+-NTA column binds proteins with 
six consecutive histidines. While this sequence rarely occurs in nature, it is present at the 
carboxy terminus of full length C-Nterm. After washing the column to remove impurities, 
0.5 M imidazole was applied to elute the protein bound to the column (Figure 10). The 
77 
sizes of the eluted protein bands were interpolated against Sigma molecular weight 
standards by linear regression. Protein bands present in samples of C-Nterm/mYEp 
transfected yeast dialysate and in material that did not bind to the affinity column were 
compared with protein bands in the eluant. In the eluted fraction, there were distinct 
protein bands between 25 kDa and 18 kDa, with the bands at 25.61 kDa and 18.78 kDa 
being the most intensely stained. Similar bands (25 kDa-18 kDa) were seen in the C-
Nterm/m YEp transfected yeast supernatant dialysate and were also seen, though noticeably 
less intense, in the C-Nterm/mYEp transfected yeast supernatant which flowed off the 
column. Higher molecular weight proteins (75 kDa to about 42 kDa) present in C-
Nterm/m YEp transfected yeast dialysate and the material which flowed through the column 
were not present in the eluted fractions. This data further suggests that the high molecular 
weight bands which did not bind to the Ni2+ affinity column represent yeast proteins. 
These data indicated that the same size proteins eluted from the column (25 kDa-18 kDa) 
were present in the initial C-Nterm/m YEp transfected yeast supernatant and that some of 
the C-Nterm protein in the C-Nterm/mYEp transfected yeast supernatant did not bind to 
the affinity column. 
Protein eluted from the Ni2+-NTA column was electrophoresed on a 15% gel and 
stained with Coomassie. This experiment was done to better evaluate the size of the lower 
molecular weight bands associated with C-Nterm. The bands were interpolated against 
Amersham and Sigma molecular weight standards to determine if there was a difference in 
size when using different standards. As mentioned in the results, the Sigma standards are 
not pre-stained and therefore provide a more accurate weight of C-Nterm. The size of C-
Nterm using Sigma standards ranged between 26 kDa-16 kDa whereas Amersham 
standards reported a range of 28 kDa-15 kDa. One interesting observation noted on other 
gels and confirmed on this higher percentage gel was that C-Nterm does not run below 15 
kDa-16 kDa (close to its reported size of 16,270 Da). This may suggest that the multiple 
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bands associated with C-Nterm represent an unmodified form (15 kDa-16 kDa) as well as 
posttranslationally modified forms (>16, 270 kDa). 
To characterize the identity of the eluted protein, immunoblots with _Anti-
r230.MBP .C, Anti-FLAG Ml, and Anti-MBP were performed (Figures 13 and 14 and 
data not shown, respectively). The Ni2+ purified protein probed with Anti-MBP showed 
no reactivity. Ni2+ purified protein was recognized, however, by both antibodies generated 
against Pfs230 region C and the antibodies to the amino terminal FLAG peptide encoded 
by mYEp. These results suggested that all the bands present in the C-Nterm/mYEp 
transfected yeast supernatant contained amino acids corresponding to Pf s230 region C and 
that the FLAG peptide was present at the amino terminus of each. The Anti-MBP blot 
suggested that the reactivity between C-Nterm and Anti-r230.MBP.C is not due to 
irnmuno-crossreactivity of the recombinant with Anti-MBP antibodies. 
Additionally, YEp transfected yeast supernatant was blotted then probed with Anti-
r230.MBP.C, Anti-FLAG Ml and Anti-MBP antibodies as a negative control. The high 
molecular weight bands associated with YEp transfected yeast in other gels (Figure 10), 
which probably represent endogenous yeast secreted proteins, showed no reactivity with 
these antibodies. This indicated that YEp transfected yeast proteins showed no irnmuno-
crossreactivity with Anti-r230.MBP.C, Anti-FLAG Ml and Anti-MBP. 
In summary, the purification of C-Nterm protein by way of Ni2+-NTA indicated 
that the carboxy terminus was present because purification required the presence of the six 
consecutive histidines on the carboxy terminus of C-Nterm. The reactivity of purified 
protein with Anti-r230.MBP.C and Anti-FLAG Ml indicated that the eluted protein 
contained amino acids corresponding to Pfs230 and that the amino terminal FLAG of C-
Nterm was present. Together, these data indicated that full length C-Nterm protein was 
expressed. 
This raises the question of why there are so many bands observed by SDS-PAGE. 
Several possible reasons, such as improper folding, mutations in the coding sequence, and 
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posttranslational modification, were considered. The possibility of disulfide bonds 
between cysteines causing non-linear migration on the SDS-PAGE gel could be ruled out 
immediately because there are no cysteines in Pfs230.C-Nterm. Heterogeneous folding of 
C-Nterm was also unlikely on the basis that the protein was evaluated on a SDS 
denaturing gel and distinct bands (in opposed to aggregate protein smears) were observed. 
Other possibilities considered for the large size of C-Nterm were base pair 
substitutions, deletions, or mutations. The C-Nterm/mYEp construct transfected into E. 
coli was manually sequenced. The first 263 base pairs of C-Nterm were read and found to 
match the reported sequence of Pfs230 with the exception of base pair #149. While this 
base pair was not seen on the autoradiograph it was confirmed to have been present by 
subsequent peptide and automated DNA sequencing. The possibility that the yeast had 
caused mutations in the protein sequence that would result in a dramatic size shift of C-
Nterm was next considered. Two peptides obtained from a Staphylococcus aureus 
digestion of the highest molecular weight C-Nterm band showed perfect sequence 
homology with amino acid 8 to amino acid 17 and amino acid 42 to amino acid 58 of the 
reported sequence of Pfs230.C-Nterm. This suggests that no mutations that could be 
responsible for a dramatic size shift in C-Nterm had occured in the first 58 amino acids of 
the protein. However, this did not rule out the possibility of mutations downstream of 
amino acid 58. Immunoblot analyses of protein isolated from C-Nterm/mYEp transfected 
yeast showed positive reaction when probed with antibodies which recognize Pfs230 
region C. Thus, the possibility of mutations present in the first 58 amino acids of the 
construct was probably not the explanation for the various sizes associated with C-Nterm. 
To determine if the yeast had caused DNA base pair substitutions, deletions, or 
mutations which resulted in a size shift of the protein, the C-Nterm/mYEp DNA 
transfected into yeast was reharvested and the resultant yC-Nterm/mYEp construct was 
digested with restriction enzymes, Kpn I and Spe I. The size of the insert recovered from 
yC-Nterm/mYEp after the digest was compared with the size of the insert present in the 
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original C-Ntenn/mYEp and the bands (as interpolated against DNA size standards) were 
confirmed to be the same size. This suggests that the yeast did not drastically rearrange C-
Nterm to cause a size shift. To be absolutely certain, however, that no ~najor 
rearrangement had taken place in the yeast, the yC-Ntenn/m YEp construct was sent for 
automated sequencing. As indicated by accurate peptide sequence and purification by a 
Ni2+ affinity column, mutations, had they occured, would have had to occur in the center 
of C-Nterm, thus restoring the reading frame for the stop codons and the six histidine tag. 
Plasmid DNA was isolated from C-Ntenn/mYEp transfected yeast and was used to 
transfect E. coli. Ampicillin resistant E. coli was selected and purified plasmid was then 
sent to the University of Chicago Sequencing Facility for automated sequencing. The 
entire Pfs230 insert and the adjacent vector regions were sequenced from both directions. 
This included the region of the m YEp vector in the 3' end of the insert that encoded two 
stop codons as well as the base pairs which encoded the Nhe I restriction site and the six 
histidine tag. All but three of the nucleotides in the yC-Ntenn/m YEp construct conformed 
to the reported sequence of Pfs230.C-Nterm. However, because the two stop codons 
present at the 3' end of C-Nterm remained intact it is unlikely that vector sequence was 
translated into protein, thus causing a larger protein. This hypothesis is also unlikely on 
the basis that the C-Nterm protein would not have been purified if any sequence existed 
downstream of the six histidine tag. The six histidine tag must be on the exposed amino 
or carboxy terminus to bind to the Ni2+-NTA affinity column (Qiagen Inc., 1992). Clearly 
the DNA sequence showed that no major rearrangements occured that dramatically altered 
the size of C-Nterm. 
The three substitutions that occured in automated sequencing of Pfs230.C-Nterm 
were present in the sequencing data from both the 5' and 3' direction. While these 
substitutions were probably not responsible for a 10 k:Da size shift of C-Nterm, they may 
present problems for future work with C-Nterm. The data indicated that base pair #170 in 
C-Nterm was a cytosine while the base reported in Pfs230 was an adenine. Base pairs 
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#329 and #392 were guanines on the chromatogram while the bases were reported as 
adenines in Pfs230. These base pair substitutions, if they were accurate, would have 
changed the primary amino acid structure of Pfs230.C-Nterm. First, amino acid 57 would 
be a serine instead of the reported leucine. Peptide sequence indicated that this amino acid 
was in fact a leucine. This raises the possibility about the validity of the base pair 
substitution reported in the automated sequencing. The two remaining base pair 
substitutions, assuming they were correct, would have caused amino acid 110 to be a 
glutamine instead of the reported glycine and amino acid 131 would be glycine and not the 
reported aspartate. Because the difference of molecular weight between these amino acids 
is negligible, it is doubtful that they are responsible for the shift in molecular weight 
observed with C-Nterm. The isoelectric charges on the amino acids that may have been 
substituted are consistent in glutamine and glycine, but glycine (pl 5.97) and aspartate (pl 
2.77) differ substantially. The change in pl of one amino acid would probably not alter 
the entire pl of a protein and could probably not cause a shift of up to 10 kDa of the C-
Nterm protein on a denaturing polyacrylamide gel. Also, the running buffer used for the 
gel was pH 6.8. This is a higher pH than the pl value of both glycine and aspartate. 
When pH is higher than pl these residues are negatively charged and migrate towards the 
positive electrode. While aspartate is slightly more negative than glycine this difference 
would be negligible with respect to migration pattern assuming the SDS had adequately 
bound to C-Nterm. 
Since C-Nterm multimers were unlikely because it does not contain cysteines and 
because C-Nterm was evaluated on a SDS denaturing gel, and no major sequence 
rearrangements existed that could explain the large size of C-Nterm, posttranslational 
modification of the protein was considered. The most common modification of secreted 
yeast proteins is glycosylation, specifically N-linked to asparagines. C-Nterm lacks the 
requisite asn-x-ser sequence so it is unlikely that it was N-link glycosylated but 0-link 
glycosylation was still a possibility. A glycoprotein detection kit was used to determine if 
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carbohydrate moieties were present on C-Nterm. No staining was seen in the purified 
fractions of yeast transfected with C-Nterm/mYEp. Only high molecular weight proteins 
(specifically proteins from 98 kDa to 41 kDa) present in crude C-Nterm/mYEp transfected 
yeast supernatant and material which flowed through the affinity column were stained 
(Figure 16) . C-Nterm migrates from roughly 30 kDa to 16 kDa and no bands below 41 
k:Da were stained. It was certain that the transfer of C-Nterm protein was successful 
because staining of the nitrocellulose with ponceau S revealed bands in the 30 kDa to 16 
k:Da range (data not shown). Taken together, these facts suggested that the detection kit 
used was able to identify glycoproteins produced by yeast and that C-Nterm was not 
glycosylated. 
Other possible posttranslational modifications, notably fatty acylation (i.e. 
isoprenylation, palmitoylation, and myristoylation (cotranslational)), sulfation, and 
phosphorylation could also lead to a larger protein. Isoprenylation is a type of fatty acid 
addition which takes on two forms: a 15 carbon isoprenyl lipid, famesyl; a 20 carbon 
lipid, geranylgeranyl (Schafer and Rine, 1992). Both isoprenoids add in thioester linkage 
to cysteines at the carboxy terminus of a protein. Consensus sequences for isoprenyl 
addition are: CAAX (where X determines which type of prenyl addition occurs); CXC 
and CL in which one or both cysteines are geranylgeranylated (Caldwell et al., 1995). 
Palmitoylation is another type of fatty acylation which involves the posttranslational 
attachment of a 16 carbon chain to the thiol group of any cysteine throughout the body of a 
polypeptide (Casey, 1995). Because C-Nterm contains no cysteines isoprenylation and 
palmitoylation could not have occured. Myristoylation, which actually occurs 
cotranslationally, involves the addition of a 14 carbon chain to the amino terminal glycine 
residue in the consensus sequence Met-Gly-X-X-X-Serffhr, where the Met is cleaved 
(Resh, 1994). C-Nterm, with the FLAG peptide as its first 15 amino acids, has an amino 
terminal aspartate not glycine and therefore myristoylation could not have occured Fatty 
acylation is also an unlikely explanation because it is commonly a modification of cytosolic 
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proteins which appears to mediate interactions between proteins and cellular membranes 
exposed to the cytosol (Alberts, et al., 1994). C-Nterm, of course, is a secreted protein 
isolated from the yeast media with no transmembrane domain. Once a protein is in the 
secretory pathway it remains inside the endomembranous system and does not appear in 
the cytosol (Stryer et al., 1995). 
Sulfation and phosphorylation may be possible contributing factors for the 
increased size of C-Nterm. Sulfate groups are covalently added to tyrosines and/or 
carbohydrate residues of secretory proteins in the Golgi complex (Rosa et al., 1985). 
Phosphate groups are added to the hydroxyl group of serine, threonine or tyrosine 
residues. Gel shift assays have shown three phosphoryl additions can correlate with as 
much as a 20 kDa increase in size (Izumi and Maller, 1993). C-Nterm has 13 serines, 
seven threonines, and eight tyrosines. It is possible that sulfation and phosphorylation are 
modifications that take place in parasite-produced Pfs230. In the 360 kDa form of the 
protein and the processed 310 kDa form of the protein it is difficult to detect a 10 kDa size 
shift. Both of these forms of the protein migrate as a doublet which could be due to 
sequential proteolysis. However, these doublets may be due to posttranslational 
modification by the parasite in the form of 0-linked glycosylation, sulfation, or 
phosphorylation. 
Due to the uncertainty associated with the size of C-Nterm, the question remains is 
this project worth exploring further and how can the results of this project be of future 
use? It is clear that the m YEp vector constructed in this project will be useful in future 
studies. The vector has already been sent to two other investigators to be used in their 
experimental work. The six histidine tag and the Nhe I restriction site as well as the 
additional stop codon added provide this vector with unique advantages absent in its 
unmodified counterpart. Proteins expressed with this vector have the ability of being 
purified through the amino terminus (FLAG) and the carboxy terminus (6 his). 
Alternatively, a construct could be created using the Kpn I restriction site (outside of the 
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MCS) to generate a protein with only a six histidine tag. In addition, the Nhe I site can 
serve the dual purpose of distinguishing m YEp from unmodified YEp and can be used for 
compatible end ligations to generate future constructs. The additional stop codon serves as 
a precaution and is also an asset to m YEp. 
With respect to C-Nterm, this project has demonstrated that under the reaction 
conditions used, proteins of this size can be efficiently expressed. This is evident by the 
amount of protein eluted from the affinity column. Like m YEp, C-Nterm may also play a 
role in future studies. C-Nterm has the FLAG peptide at the amino terminus which may 
prove useful for amino terminal purification and immunoblot analyses. Furthermore, the 
FLAG/C-Nterm fusion protein may also be used to determine if C-Nterm contains the site 
where the 360 kDa form of Pfs230 is processed to the 310 kDa form. Conversely, C-
Nterm may be more beneficial without the FLAG because the FLAG peptide is highly 
immunogenic and may overpower any immune response generated to recombinant C-
Nterm. 
The question as to whether C-Nterm will be useful as an immunogen at all remains 
unclear. It is possible that the multiple band pattern associated with C-Nterm represents 
posttranslational modifications added by the yeast. There is a chance that these 
modifications might affect conformationally dependent epitopes in the protein. However, 
if the multiple band pattern represents posttranslational modifications and these 
modifications mimic modifications that actually occur in the parasite, this could be 
advantageous. The nucleotide substitutions which occured in C-Nterm according to 
automated sequencing, however, need to be seriously considered. While there was no 
indication that these substitutions caused a shift in the reading frame, it is possible that 
they may interfere with antibody recognition if the substitutions occured at crucial 
epitopes. 
Because C-Nterm was designed to be an immunogen, future projects in the lab 
with the protein would probably first involve mice immunizations. If it is determined that 
85 
C-Nterm solicits an immune response with a good IgG titer, studies to resolve the size 
issue will then be conducted. These experiments might include: 1) Detecting sulfation or 
phosphorylation in C-Nterm by labeling the recombinant with 35 S sulfate or 32P 
orthophosphoric acid, respectively; 2) Running C-Nterm on a tricine gel to determine if 
SDS-PAGE anomalies are contributing to the various sizes associated with C-Nterm; 3) 
Isoelectric focusing - if different pl' s are associated with different bands this may make 
more of a case for phosphorylation or sulfation because these modifications would alter 
the pl; 4) Creating a C-Nterm/mYEp construct without the FLAG peptide which may be a 
better candidate for immunizing. 
CHAPTER V 
CONCLUSION 
In conclusion, Western blot analysis and sequencing results indicated that Pfs230 
amino acid 447 to amino acid 584 (C-Nterm) was expressed as a secreted protein in S. 
cerevisiae. The protein was targeted to the yeast secretory pathway via the a signal 
sequence encoded by the m YEp vector. The leader sequence was properly removed in the 
yeast leaving the FLAG peptide at the amino terminus of C-Nterm. This was determined 
because Anti-FLAG Ml, which is specific for FLAG on the exposed amino terminus of a 
protein, recognized recombinant C-Nterm. The yeast secreted protein was further shown 
to contain amino acids from region C of Pfs230 by immunoblot analysis with Anti-
r230.MBP.C and amino acid sequencing. The recombinant protein was also determined 
to have the six histidine sequence at its carboxy terminus due to the fact that it was purified 
using a Ni2+-NTA affinity column. This, coupled with the Anti-r230.MBP.C and Anti-
FLAG Ml reactivity, suggested that full length yeast produced Pfs230.C-Nterm was in 
hand. 
The primary DNA sequence of C-Nterm/mYEp was shown to be full length and in 
the proper reading frame by DNA sequencing. Protein sequencing of recombinant C-
Nterm generated two peptides with perfect sequence homology to amino acid 8 to amino 
acid 17 and amino acid 42 to amino acid 58 of the reported sequence of Pfs230.C-Nterm. 
Automated sequencing of yC-Nterm/m YEp showed three base pair substitutions when 




Secreted C-Nterm migrates on SDS-PAGE as a number of distinct bands. The 
precise reason for this remains unclear. All of the bands appear to be full length. 
containing both the amino terminal FLAG sequence and the six histidine tag. There .is no 
evidence for a rearranged internal DNA sequence. While the protein does not appear to be 
glycosylated, phosphorylation may be a possible explanation as to why C-Nterm migrates 
as so many bands. It is difficult to find a pattern among the bands on every gel. 
However, many gels seem to show a one to three kDa increase in size between the bands. 
It is possible that each of these bands represents a different degree of modification and that 
the lowest molecular weight band (which seems to migrate between 15 kDa-16 kDa 
depending on the gel) represents the unmodified C-Nterm protein. Currently, little is 
known about specific modifications of parasite-produced Pfs230, but it is possible that 
Pfs230 is posttranslationally modified by the parasite. 
Possible immediate uses of C-Nterm include testing its immunogenicity in mice 
and determining whether the antibodies generated will recognize parasite-produced 
Pfs230. If antisera generated to C-Nterm recognizes parasites by immunofluoresence 
assay, it would then be tested for its ability to block parasite infectivity in the mosquito. 
Because C-Nterm is designed to be used as an immunological reagent and not a chemical 
reagent it will first be necessary to determine if decent antibody titer can be generated in 
mice. If C-Nterm proves to be immunogenic, the issue of posttranslational modification 
as a possible reason for the various sizes will be dealt with further. 
Another possibility for C-Nterm is to test this region for its role in stage-specific 
processing of Pfs230 from the 360 kDa form to the 310 kDa form. It is predicted that the 
clip site for Pfs230 exists within C-Nterm. To test this, recombinant protein could be 
incubated in parasite extract then size fractionated to determine if the parasites have 
protealyzed the protein to its smaller form. If the size of the protein recognized by Anti-
FLAG Ml decreases after incubation with the parasite extract this would indicate that 
processing of the molecule had occured. 
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